<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7596660</article-id><article-id pub-id-type="doi">10.3389/fmicb.2020.571093</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Identification of Growth Inhibitors of the Fish Pathogen <italic>Saprolegnia parasitica</italic> Using <italic>in silico</italic> Subtractive Proteomics, Computational Modeling, and Biochemical Validation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Sanjiv</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/308954/overview"/></contrib><contrib contrib-type="author"><name><surname>Mandal</surname><given-names>Rahul Shubhra</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/308954/overview"/></contrib><contrib contrib-type="author"><name><surname>Bulone</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/27764/overview"/></contrib><contrib contrib-type="author"><name><surname>Srivastava</surname><given-names>Vaibhav</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="c001" ref-type="corresp"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/190505/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Division of Glycoscience, Department of Chemistry, School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institute of Technology (KTH), AlbaNova University Centre</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Cancer Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>United States</country></aff><aff id="aff3"><sup>3</sup><institution>School of Agriculture, Food and Wine, The University of Adelaide</institution>, <addr-line>Adelaide, SA</addr-line>, <country>Australia</country></aff><author-notes><fn id="fn1" fn-type="edited-by"><p>Edited by: Gustavo Henrique Goldman, University of S&#x000e3;o Paulo, Brazil</p></fn><fn id="fn2" fn-type="edited-by"><p>Reviewed by: Francisco P. Ch&#x000e1;vez, University of Chile, Chile; Xiao-Ren Chen, Yangzhou University, China; Filomena Nazzaro, National Research Council (CNR), Italy; Federico Vita, University of Florence, Italy</p></fn><corresp id="c001">*Correspondence: Vaibhav Srivastava, <email>vasri@kth.se</email></corresp><fn id="fn3" fn-type="other"><p>This article was submitted to Fungi and Their Interactions, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>16</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>571093</elocation-id><history><date date-type="received"><day>09</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Kumar, Mandal, Bulone and Srivastava.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Kumar, Mandal, Bulone and Srivastava</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Many Stramenopile species belonging to oomycetes from the genus <italic>Saprolegnia</italic> infect fish, amphibians, and crustaceans in aquaculture farms and natural ecosystems. <italic>Saprolegnia parasitica</italic> is one of the most severe fish pathogens, responsible for high losses in the aquaculture industry worldwide. Most of the molecules reported to date for the control of <italic>Saprolegnia</italic> infections either are inefficient or have negative impacts on the health of the fish hosts or the environment resulting in substantial economic losses. Until now, the whole proteome of <italic>S. parasitica</italic> has not been explored for a systematic screening of novel inhibitors against the pathogen. The present study was designed to develop a consensus computational framework for the identification of potential target proteins and their inhibitors and subsequent experimental validation of selected compounds. Comparative analysis between the proteomes of <italic>Saprolegnia</italic>, humans and fish species identified proteins that are specific and essential for the survival of the pathogen. The DrugBank database was exploited to select food and drug administration (FDA)-approved inhibitors whose high binding affinity to their respective protein targets was confirmed by computational modeling. At least six of the identified compounds significantly inhibited the growth of <italic>S. parasitica in vitro</italic>. Triclosan was found to be most effective with a minimum inhibitory concentration (MIC<sub>100</sub>) of 4 &#x003bc;g/ml. Optical microscopy showed that the inhibitors affect the morphology of hyphal cells, with hyper-branching being commonly observed. The inhibitory effects of the compounds identified in this study on <italic>Saprolegnia</italic>&#x02019;s mycelial growth indicate that they are potentially usable for disease control against this class of oomycete pathogens. Similar approaches can be easily adopted for the identification of potential inhibitors against other plant and animal pathogenic oomycete infections.</p></abstract><kwd-group><kwd>disease control</kwd><kwd>fish pathogen</kwd><kwd>growth inhibitors</kwd><kwd>oomycete</kwd><kwd><italic>Saprolegnia parasitica</italic></kwd><kwd><italic>in silico</italic> proteomics</kwd></kwd-group><funding-group><award-group><funding-source id="cn1">European Commission<named-content content-type="fundref-id">10.13039/501100000780</named-content></funding-source><award-id rid="cn1">828940</award-id></award-group><award-group><funding-source id="cn2">Swedish Research Council FORMAS<named-content content-type="fundref-id">10.13039/501100001862</named-content></funding-source><award-id rid="cn2">#2019-00912</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="2"/><equation-count count="0"/><ref-count count="103"/><page-count count="12"/><word-count count="10002"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Most species from the oomycete genus <italic>Saprolegnia</italic> are opportunistic parasites (<xref rid="ref69" ref-type="bibr">Plumb, 1999</xref>) that cause the disease saprolegniasis in various fish species (<xref rid="ref95" ref-type="bibr">van West, 2006</xref>), amphibians (<xref rid="ref8" ref-type="bibr">Blaustein et al., 1994</xref>), crustaceans (<xref rid="ref20" ref-type="bibr">Di&#x000e9;guez-Uribeondo et al., 1994</xref>), and other aquatic animals (<xref rid="ref25" ref-type="bibr">Fernandez-Beneitez et al., 2011</xref>). The virulent strains of <italic>Saprolegnia parasitica</italic> infect eggs, juvenile, and adult fish, leading to important losses in fish farms worldwide (<xref rid="ref95" ref-type="bibr">van West, 2006</xref>). The chemical malachite green was used effectively for the treatment of saprolegniasis (<xref rid="ref98" ref-type="bibr">Willoughby and Roberts, 1992</xref>) until it was banned in 2002 by the United States and several other countries due to its carcinogenic and mutagenic effects in humans and animals (<xref rid="ref83" ref-type="bibr">Srivastava et al., 2004</xref>). The aquaculture production is increasing every year, and due to the lack of suitable and effective chemicals to control saprolegniasis, a re-emergence and spread of the disease is observed worldwide. Losses due to <italic>S. parasitica</italic> are higher in fish farms than in wild environments because the farmed animals are typically held in high densities and exposed to constant stress and various types of pollutants, factors that altogether increase the risk of infection and spread of the disease.</p><p>To date, multiple chemicals have been trialed to control saprolegniasis (<xref rid="tab1" ref-type="table">Table 1</xref>), but their negative impact on the environment or the health of fish farmers or the fish hosts typically prevents their practical use in aquaculture. Two main classes of molecules have been investigated that have either general antimicrobial activity or a more targeted mode of action. From the first class, the least harmful compound is sodium chloride, but this salt is efficient only at high concentrations, which makes its use impractical in freshwater (<xref rid="ref17" ref-type="bibr">Das et al., 2012</xref>). Hydrogen peroxide also has minimal impact on the environment and has been used to efficiently treat <italic>Saprolegnia</italic> infections in catfish (<xref rid="ref36" ref-type="bibr">Howe et al., 1999</xref>). More recently, however, its application has been shown to provoke negative side effects, such as reduced fish growth and damage to the gills (<xref rid="ref56" ref-type="bibr">Mustafa, 2019</xref>). Likewise, while boric acid inhibits germination and colonization of spores as well as mycelial growth in <italic>Saprolegnia</italic> species (<xref rid="ref2" ref-type="bibr">Ali et al., 2014</xref>), an excess of boron affects DNA integrity of blood and sperm cells in Nile tilapia (<xref rid="ref1" ref-type="bibr">Acar et al., 2018</xref>) and adversely impacts the growth of rainbow trout (<xref rid="ref66" ref-type="bibr">&#x000d6;z et al., 2018</xref>). Peracetic acid is another nonspecific antimicrobial chemical with proven activity against <italic>S. parasitica</italic> (<xref rid="ref50" ref-type="bibr">Marchand et al., 2012</xref>), but its use in fish farms is hindered by the fact that it causes lacrimation at low concentrations as well as extreme discomfort and irritation of the upper respiratory tract in humans (<xref rid="ref58" ref-type="bibr">N. R. Council, 2010</xref>). Other efficient compounds have adverse effects on the environment. Examples are formaldehyde, sometimes used for the treatment of eggs and larval stages (<xref rid="ref30" ref-type="bibr">Gieseker et al., 2006</xref>), and copper sulfate, which inhibits <italic>Saprolegnia</italic> growth by affecting multiple biological functions, including protein and energy biogenesis (<xref rid="ref37" ref-type="bibr">Hu et al., 2016</xref>).</p><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>List of compounds reported earlier to be effective in controlling the growth and spread of <italic>S. parasitica</italic> in aquaculture.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Drugs</th><th align="left" valign="top" rowspan="1" colspan="1">Effective concentration</th><th align="left" valign="top" rowspan="1" colspan="1">Target/Mechanism</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">NaCl</td><td align="left" valign="middle" rowspan="1" colspan="1">~15 mg/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref400" ref-type="bibr">Marking et al., 1994</xref>; <xref rid="ref17" ref-type="bibr">Das et al., 2012</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Formalin</td><td align="left" valign="middle" rowspan="1" colspan="1">0.1 mg/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref30" ref-type="bibr">Gieseker et al., 2006</xref>; <xref rid="ref41" ref-type="bibr">Khodabandeh and Abtahi, 2006</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Boric acid</td><td align="left" valign="middle" rowspan="1" colspan="1">0.5 mg/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Germination and colonization</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref2" ref-type="bibr">Ali et al., 2014</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Peracetic acid</td><td align="left" valign="middle" rowspan="1" colspan="1">4&#x02013;10 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref50" ref-type="bibr">Marchand et al., 2012</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hydrogen peroxide</td><td align="left" valign="middle" rowspan="1" colspan="1">50&#x02013;250 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref55" ref-type="bibr">Mitchell and Collins, 1997</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Clotrimazole</td><td align="left" valign="middle" rowspan="1" colspan="1">~1&#x02013;2 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">CYP51 sterol 14&#x003b1;-demethylase</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref96" ref-type="bibr">Warrilow et al., 2014</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Copper sulfate</td><td align="left" valign="middle" rowspan="1" colspan="1">0.5 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Protein and energy biogenesis</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref85" ref-type="bibr">Sun et al., 2014</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bronopol</td><td align="left" valign="middle" rowspan="1" colspan="1">30 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Dehydrogenase inhibitor</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref71" ref-type="bibr">Pottinger and Day, 1999</xref>; <xref rid="ref10" ref-type="bibr">Branson, 2002</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Saprolmycins A&#x02013;E angucycline antibiotic</td><td align="left" valign="middle" rowspan="1" colspan="1">3.9&#x02013;7.8 ng/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Unknown, probably histidine kinases inhibitor</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref59" ref-type="bibr">Nakagawa et al., 2012</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chitosans</td><td align="left" valign="middle" rowspan="1" colspan="1">~0.4 mg/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Fungicidal</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref57" ref-type="bibr">Muzzarelli et al., 2001</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Oridamycins</td><td align="left" valign="middle" rowspan="1" colspan="1">3.0 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref87" ref-type="bibr">Takada et al., 2010</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dioscin</td><td align="left" valign="middle" rowspan="1" colspan="1">2.0 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Damages mycelium, accumulation of reactive oxygen species</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref46" ref-type="bibr">Liu et al., 2015</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Amphotericin B</td><td align="left" valign="middle" rowspan="1" colspan="1">5.0 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Sterol biosynthesis</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref9" ref-type="bibr">Bly et al., 1996</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cladomarine/Cladosporin</td><td align="left" valign="middle" rowspan="1" colspan="1">13&#x02013;23 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Probable lysyl-tRNA synthetase inhibitor</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref88" ref-type="bibr">Takahashi et al., 2017</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Malachite green</td><td align="left" valign="middle" rowspan="1" colspan="1">1.0 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Affects multiple proteins</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref52" ref-type="bibr">Martin, 1968</xref>; <xref rid="ref98" ref-type="bibr">Willoughby and Roberts, 1992</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nikkomycin Z</td><td align="left" valign="middle" rowspan="1" colspan="1">25&#x02013;99 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Chitin synthases inhibitor</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref33" ref-type="bibr">Guerriero et al., 2010</xref>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Benzoic acid</td><td align="left" valign="middle" rowspan="1" colspan="1">100 &#x003bc;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" rowspan="1" colspan="1"><xref rid="ref90" ref-type="bibr">Tedesco et al., 2019</xref>
</td></tr></tbody></table></table-wrap><p>Other chemicals with more specific modes of action have been tested against <italic>Saprolegnia</italic> species. For example, bronopol (2-bromo-2-nitropropane-1,3-diol) and its methyl derivative 2-methyl-4-isothiazolin-3-one oxidize thiol groups in proteins and are, as such, inhibitors of dehydrogenases. These chemicals have been identified as promising compounds for the control of <italic>Saprolegnia</italic> infections in ova and adult fish (<xref rid="ref10" ref-type="bibr">Branson, 2002</xref>; <xref rid="ref63" ref-type="bibr">Oono and Hatai, 2007</xref>), although tolerant strains of <italic>Saprolegnia</italic> have been reported (<xref rid="ref74" ref-type="bibr">Rezinciuc et al., 2014</xref>). Further chemicals of the oxyalkylchalcone class have been developed to overcome bronopol resistance. Promising molecules with higher inhibitory activity than bronopol on <italic>Saprolegnia</italic> growth are 2',4'-dihydroxychalcone and its oxyalkylated derivative produced by chemical synthesis, 2-hydroxy, 4-farnesyloxychalcone (<xref rid="ref28" ref-type="bibr">Flores et al., 2016</xref>). However, these molecules were tested <italic>in vitro</italic> only and there are no results that demonstrate both their efficiency in infected animals and innocuousness to the environment. An attractive alternative approach to the chemical synthesis of novel inhibitors is the search for natural molecules that exhibit antimicrobial properties. Relevant examples that have been shown to be effective against <italic>S. parasitica</italic> with weak or no activity against fungi, bacteria, microalgae, or zooplankton are the angucycline antibiotics saprolmycins A and E from <italic>Streptomyces</italic> sp. (<xref rid="ref59" ref-type="bibr">Nakagawa et al., 2012</xref>). Likewise, cladomarine and quellenin, two antibiotics produced by the deep-sea fungus <italic>Penicillium coralligerum</italic> (YK-247) and <italic>Aspergillus</italic> sp. (strain YK-76), respectively, were shown to exhibit anti-<italic>Saprolegnia</italic> activity (<xref rid="ref88" ref-type="bibr">Takahashi et al., 2017</xref>). However, despite the discovery of these promising natural anti-oomycete compounds, their large-scale production has proven to be challenging and too expensive to be commercially viable.</p><p>Despite the numerous efforts mentioned above, we are still lacking compounds that can be used in the aquaculture industry to tackle saprolegniasis. Bioinformatic approaches have allowed the identification of inhibitors of bacterial pathogens of humans (<xref rid="ref81" ref-type="bibr">Solanki and Tiwari, 2018</xref>; <xref rid="ref5" ref-type="bibr">Bhardwaj et al., 2019</xref>; <xref rid="ref15" ref-type="bibr">Cesur et al., 2020</xref>). Inspired by these successful strategies, here, we aim to identify specific protein targets and potential lead inhibitors of <italic>S. parasitica</italic> using combined <italic>in silico</italic> subtractive proteomics with a sequence-based approach. Our strategy presented in <xref rid="fig1" ref-type="fig">Figure 1</xref> consisted in the analysis of the whole predicted proteome of <italic>S. parasitica</italic> and its comparison with fish and human proteomes to identify non-homologous essential proteins from the pathogen. The DrugBank database was subsequently searched to select potential food and drug administration (FDA)-approved inhibitors of these proteins, which were subsequently tested <italic>in vitro</italic> for their efficacy in arresting the growth of <italic>S. parasitica</italic>. With this approach, we have identified several inhibitors that exhibit MIC<sub>100</sub> as low as 4 &#x003bc;g/ml. Their interactions with their protein targets were also studied by computational modeling, providing further evidence of the specific nature of the observed inhibitory effects. Similar strategy to identify and test novel compounds can be extended to other pathogenic oomycetes.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Schematic representation of the subtractive proteomics approach used in the present study. The whole proteome of <italic>Saprolegnia parasitica</italic> was searched using blastp (E-value &#x0003c; 1.0E-03, bitscore &#x0003e; 100) against human and fish proteomes followed by Database of Essential Genes (DEG) and finally, against DrugBank database for identification of food and drug administration (FDA)-approved inhibitor compounds.</p></caption><graphic xlink:href="fmicb-11-571093-g001"/></fig></sec><sec sec-type="materials|methods" id="sec2"><title>Materials and Methods</title><sec id="sec3"><title>Identification of Non-homologous Essential Proteins</title><p>The predicted proteome of <italic>S. parasitica</italic> (strain CBS 223.65) was retrieved from the NCBI website<xref ref-type="fn" rid="fn001"><sup>1</sup></xref> using genome assembly ASM15154v2. Conserved protein domains were predicted using pfam v31.0 (<xref rid="ref26" ref-type="bibr">Finn et al., 2016</xref>) and conserved domain database (CDD; <xref rid="ref51" ref-type="bibr">Marchler-Bauer et al., 2017</xref>). Protein sequences deduced from the human (<italic>Homo sapiens</italic> GRCh38.p11) and 15 fish genomes (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S1</xref>) were compared with the sequences from <italic>S. parasitica</italic> using blastp (BLAST 2.2.31+). The <italic>Saprolegnia</italic> proteins that did not present any significant sequence similarity (E-value &#x0003c; 1.0E-03, bitscore &#x0003e; 100) with any of the human or fish proteins were considered as non-homologous and used for further analysis. Their sequences were searched against the Database of Essential Genes (DEG v15.2; <xref rid="ref47" ref-type="bibr">Luo et al., 2014</xref>) using blastp to create a list of essential proteins from <italic>S. parasitica</italic>. The DEG database comprises genes from <italic>archaea</italic>, bacteria, and eukaryotes that are known to be vital for the organism considered. As it is generally assumed that proteins essential to one organism are also likely to be essential to other organisms, proteins from <italic>S. parasitica</italic> similar to proteins from the DEG database, i.e., proteins with an E-value &#x0003c; 1.0E-05 and a bitscore &#x0003e; 100, were considered as potential targets of anti-oomycete compounds and used for further analysis.</p></sec><sec id="sec4"><title>Druggability Potential of Non-homologous Essential Proteins</title><p>An effective way to estimate the druggability of a protein, i.e., its capacity to bind one or several inhibitors, is to identify in the first instance similar proteins that have been shown to interact with these inhibitors (<xref rid="ref40" ref-type="bibr">Keller et al., 2006</xref>). The DrugBank database (v5.1.1; <xref rid="ref99" ref-type="bibr">Wishart et al., 2018</xref>) is a unique collection of bioinformatic and cheminformatic resources that combines drug data with information on the corresponding protein targets. The non-homologous essential proteins from <italic>S. parasitica</italic> identified as described above were searched against the DrugBank database using blastp. The proteins that showed significant scores (E-value &#x0003c; 1.0E-05, bitscore &#x0003e; 100) and their corresponding FDA-approved compounds were further considered.</p></sec><sec id="sec5"><title>Homology Modeling and Docking</title><p>Homology modeling was performed using the CPHmodels 3.2 Server (<xref rid="ref61" ref-type="bibr">Nielsen et al., 2010</xref>) that uses profile-profile alignment guided by protein secondary structure and exposure predictions for template identification. The generated models were further minimized using Steepest Descent and the conjugate gradient method in Discovery Studio 2.5 (<xref rid="ref7" ref-type="bibr">Biovia, 2018</xref>). The models were used for molecular docking with selected lead compounds using AutoDock Vina (<xref rid="ref93" ref-type="bibr">Trott and Olson, 2010</xref>) in PyRx (<xref rid="ref16" ref-type="bibr">Dallakyan, 2008</xref>) with default parameters. The 3D structures of the active compounds were retrieved from the DrugBank database and minimized in PyRx before docking. The docked complexes were further visualized using PyMol (<xref rid="ref78" ref-type="bibr">Seeliger and de Groot, 2010</xref>) and LigPlot+ (<xref rid="ref42" ref-type="bibr">Laskowski and Swindells, 2011</xref>), and the corresponding binding energies were calculated using AutoDock Vina (<xref rid="ref93" ref-type="bibr">Trott and Olson, 2010</xref>).</p></sec><sec id="sec6"><title><italic>Saprolegnia</italic> Cultures and Test of Growth Inhibitors</title><p><italic>S. parasitica</italic> (strain CBS223.65) was maintained on potato dextrose agar (PDA) by inoculating Petri dishes with agar plugs carrying pre-grown mycelium. The cultures were kept at 24&#x000b0;C in the dark, and inoculations were repeated every 15 days. Growth inhibition experiments were conducted in the synthetic medium of <xref rid="ref48" ref-type="bibr">Machlis (1953)</xref>. First, sesame seeds carrying <italic>S. parasitica</italic> mycelium were prepared by spreading autoclave-sterilized seeds (121&#x000b0;C for 20 min) on PDA plates that contained a central agar plug covered with mycelium. After 5 days at 24&#x000b0;C, the seeds coated with hyphal cells were transferred to 24-well flat-bottom tissue culture plates (one seed per well) containing 1 ml Machlis medium in each well. Dilutions of the selected compounds were used to determine the effective concentration of each inhibitor (<xref rid="tab2" ref-type="table">Table 2</xref>). Copper sulfate (<xref rid="ref85" ref-type="bibr">Sun et al., 2014</xref>), boric acid (<xref rid="ref2" ref-type="bibr">Ali et al., 2014</xref>), benzoic acid (<xref rid="ref90" ref-type="bibr">Tedesco et al., 2019</xref>), and malachite green (<xref rid="ref52" ref-type="bibr">Martin, 1968</xref>), all known to be effective inhibitors of <italic>S. parasitica</italic>, were used as positive controls. Solvents of each class of inhibitor, i.e., sterile water, dimethyl sulfoxide (DMSO), ethanol, and acetone, were used as negative controls. Varying concentrations of each solvent (0.01, 0.1, 1.0, and 10.0%) were also tested to determine whether they had any effect on the growth of the mycelium (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1A</xref>,<xref ref-type="supplementary-material" rid="SM1">B</xref>). All concentrations were tested in three or more replicates. The plates were incubated at 24&#x000b0;C for 4 days, and the extent of mycelial growth in each well was observed and measured daily (colony diameter). MIC<sub>100</sub> were defined as the inhibitor concentrations for which no growth was observed in four independent replicates after 4 days of incubation at 24&#x000b0;C.</p><table-wrap id="tab2" position="float"><label>Table 2</label><caption><p><italic>In-vitro</italic> screening of the selected compounds on the growth of <italic>S. parasitica</italic> hyphal cells.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Compounds</th><th align="left" valign="top" rowspan="1" colspan="1">Solvent</th><th align="center" valign="top" rowspan="1" colspan="1">MIC range (&#x003bc;g/ml)</th><th align="center" valign="top" rowspan="1" colspan="1">MIC in Machlis medium (&#x003bc;g/ml)</th><th align="center" valign="top" rowspan="1" colspan="1">MIC in PDA plates (&#x003bc;g/ml)</th><th align="center" valign="top" rowspan="1" colspan="1">Microscopy (&#x003bc;g/ml)</th><th align="left" valign="top" rowspan="1" colspan="1">SPRG targets</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Triclosan</td><td align="left" valign="middle" rowspan="1" colspan="1">Acetone</td><td align="center" valign="middle" rowspan="1" colspan="1">4&#x02013;6</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_20215</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Acetohydroxamic acid</td><td align="left" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">600&#x02013;800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">600</td><td align="center" valign="middle" rowspan="1" colspan="1">600</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_06801</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sulfamethoxazole</td><td align="left" valign="middle" rowspan="1" colspan="1">DMSO</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_19504</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chloramphenicol</td><td align="left" valign="middle" rowspan="1" colspan="1">Ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_35021</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Azelaic acid</td><td align="left" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="center" valign="middle" rowspan="1" colspan="1">800</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_13682</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Benzoic acid</td><td align="left" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">400&#x02013;600</td><td align="center" valign="middle" rowspan="1" colspan="1">600</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_02663</td><td align="left" valign="top" rowspan="1" colspan="1">This study, (<xref rid="ref90" ref-type="bibr">Tedesco et al., 2019</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glycerol</td><td align="left" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;1,000</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_01876</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Albendazole</td><td align="left" valign="middle" rowspan="1" colspan="1">DMSO</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;1,000</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_07119</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Thiabendazole</td><td align="left" valign="middle" rowspan="1" colspan="1">DMSO</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;1,000</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="left" valign="middle" rowspan="1" colspan="1">SPRG_07119</td><td align="left" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Copper sulfate</td><td align="left" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="left" valign="middle" rowspan="1" colspan="1">Control</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="ref85" ref-type="bibr">Sun et al., 2014</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Boric acid</td><td align="left" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="center" valign="middle" rowspan="1" colspan="1">400</td><td align="left" valign="middle" rowspan="1" colspan="1">Control</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="ref2" ref-type="bibr">Ali et al., 2014</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Malachite green</td><td align="left" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8&#x02013;1.0</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8</td><td align="left" valign="middle" rowspan="1" colspan="1">Control</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="ref52" ref-type="bibr">Martin, 1968</xref>)</td></tr></tbody></table><table-wrap-foot><p>ND, not determined.</p></table-wrap-foot></table-wrap><p>Additional growth inhibition experiments were conducted on PDA plates. These were prepared using the MIC<sub>100</sub> determined in the Machlis medium and the same positive and negative controls as listed above (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref>). Mycelial growth was quantified by measuring the diameter of the colonies on the PDA plates pre-inoculated with single agar plugs (5 mm) placed at the center of the plates. Experiments were conducted in triplicates and measurements of colony diameters were made at 0 (day 0), 24 (day 1), 48 (day 2), and 72 h (day 3) of culture at 24&#x000b0;C (<xref rid="fig2" ref-type="fig">Figure 2</xref>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Relative growth of <italic>S. parasitica</italic> on potato dextrose agar (PDA) plates. Growth of mycelium (measured as diameter in cm) in the presence of sub-inhibitory concentrations of the tested compounds after 0 (day 0), 24 (day 1), 48 (day 2), and 72 h (day 3) of culture at 24&#x000b0;C. Four independent replicates were measured for each drug. A Student&#x02019;s <italic>t</italic>-test was also performed to check significant differences between drug treated samples compared to the sample without drug (<sup>*</sup><italic>p</italic> &#x0003c; 0.0001).</p></caption><graphic xlink:href="fmicb-11-571093-g002"/></fig></sec><sec id="sec7"><title>Optical Microscopy</title><p>The effect of the tested compounds on the morphology of hyphal cells was observed by optical microscopy in 24-well flat-bottom tissue culture plates which contained 1 ml Machlis medium and appropriate dilutions of the lead compounds. Controls were performed in parallel as indicated above. Observations were made using a Leica Microsystems Ltd. DFC295 optical microscope, and images were recorded using the Leica Application Suite software v4.1.0.</p></sec></sec><sec id="sec8"><title>Results and Discussion</title><sec id="sec9"><title>Identification of Non-homologous Essential Proteins in <italic>S. parasitica</italic> and <italic>in silico</italic> Selection of Growth Inhibitors</title><p>To identify essential pathogen-specific proteins and potential specific growth inhibitors of <italic>S. parasitica</italic>, the sequences of all predicted proteins from the pathogen were compared with human and fish protein sequences (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S1</xref>). Among the 20,121 proteins encoded by the genome of <italic>S. parasitica</italic>, 5,990 were similar to human or fish proteins and were therefore disregarded for further analysis (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Out of the remaining 14,131 non-homologous proteins, 3,012 showed significant similarity with essential proteins in the DEG database. These proteins were considered essential for <italic>S. parasitica</italic> and used for further analysis (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S2</xref>). Out of these, 117 were similar to target sequences in the DrugBank database, yielding 231 DrugBank unique entries, of which 45 are FDA approved (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S3</xref>). As the DrugBank database enlists not only inhibitors for their respective proteins but also interacting compounds, six of these 45 entries (DB01987, DB03147, DB03247, DB00140, DB09510, and DB09513) were unlikely to be efficient inhibitors. Hence, the list of potential inhibitors of growth was narrowed down to 39 compounds (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S3</xref>). These were further subdivided into two groups: the first group gathers compounds that potentially interact with two or more proteins from <italic>S. parasitica</italic>, whereas the second group consists of molecules that are predicted to bind one protein only (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S3</xref>).</p></sec><sec id="sec10"><title>Compounds Interacting With Two or More Essential Proteins From <italic>S. parasitica</italic> (Group 1)</title><p>This group contains eight compounds that can potentially interact with 29 proteins from <italic>Saprolegnia</italic> (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S3</xref>). Interestingly, among these molecules, three are semisynthetic echinocandin derivatives, namely caspofungin, anidulafungin, and micafungin. Echinocandins are well-characterized antifungal agents (<xref rid="ref31" ref-type="bibr">Gil-Alonso et al., 2015</xref>; <xref rid="ref68" ref-type="bibr">Perfect, 2017</xref>) that inhibit 1,3-&#x003b2;-<sc>d</sc>-Glucan synthases, i.e., the enzymes responsible for the formation of the major cell wall &#x003b2;-glucans in fungi. Earlier work from our group has shown that 1,3-&#x003b2;-<sc>d</sc>-glucans are major components of the cell wall of <italic>S. parasitica</italic> and other oomycete species (<xref rid="ref14" ref-type="bibr">Bulone et al., 1990</xref>; <xref rid="ref13" ref-type="bibr">Bulone and F&#x000e8;vre, 1996</xref>; <xref rid="ref54" ref-type="bibr">M&#x000e9;lida et al., 2013</xref>). 1,3-&#x003b2;-Glucan synthases have no mammalian homologues and are therefore ideal targets for antifungal and anti-oomycete inhibitors (<xref rid="ref68" ref-type="bibr">Perfect, 2017</xref>). CDD analysis of the <italic>S. parasitica</italic> proteome led to the identification of at least 10 proteins that belong to the glucan synthase family, including SPRG_05460, which was not identified in our <italic>in silico</italic> screening as an echinocandin-binding protein. We did test multiple echinocandins in previous work and showed that they do not inhibit the 1,3-&#x003b2;-Glucan synthases of <italic>Saprolegnia in vitro</italic> and are therefore unlikely to stop the growth of this class of micro-organisms (<xref rid="ref12" ref-type="bibr">Bulone, 1992</xref>). This probably reflects different properties between the fungal and oomycete enzymes as one would expect given their low level of similarity, which our blast results revealed to be of 29&#x02013;34%.</p><p>Picric acid, citric acid, and artenimol are three other compounds from this group of inhibitors. However, their specificity is predicted to be low, essentially because of their general antimicrobial activity. Indeed, picric acid has been used as an antiseptic for a long time (<xref rid="ref92" ref-type="bibr">Tidy, 1915</xref>) and is predicted to inhibit at least eight proteins from <italic>S. parasitica</italic> (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S3</xref>). The same applies to citric acid, which we have predicted to interact with at least four proteins from <italic>S. parasitica</italic>, including two uncharacterized proteins (SPRG_06530, a probable FtsZ protein, and SPRG_11850 and a phosphoribosylaminoimidazole carboxylase), a tryptophan synthase (SPRG_05079) and a cell division protein FtsZ (SPRG_11942). Tryptophan synthase catalyzes the final step of the tryptophan biosynthetic pathway. This enzyme is absent in mammals, which makes it an attractive target for many other pathogens (<xref rid="ref79" ref-type="bibr">Shen et al., 2009</xref>). The cell division protein FtsZ has been described as a potential drug target in various bacterial pathogens (<xref rid="ref79" ref-type="bibr">Shen et al., 2009</xref>), and phosphoribosylaminoimidazole carboxylase has been proposed previously as a target for drug therapy against <italic>Candida albicans</italic> (<xref rid="ref21" ref-type="bibr">Donovan et al., 2001</xref>). Despite these observations, the diversity of enzymes and non-catalytic proteins to which citric acid potentially binds to suggests that its mode of action is not specific. Similarly, artenimol (dihydroartemisinin) is predicted to interact with at least two different <italic>Saprolegnia</italic> proteins, namely SPRG_00366, a predicted pyridoxal biosynthesis lyase (PdxS), and SPRG_09913, a negative regulator of GroEL domains. Interestingly, this compound has been shown to be active against a range of organisms as diverse as viruses (<xref rid="ref23" ref-type="bibr">Efferth et al., 2008</xref>), malarial protozoa (<xref rid="ref73" ref-type="bibr">Pull et al., 2019</xref>), plant pathogenic fungi (<xref rid="ref89" ref-type="bibr">Tang et al., 2000</xref>), and even certain tumor cells (<xref rid="ref39" ref-type="bibr">Jansen et al., 2011</xref>) but its efficacy against oomycetes has not been reported.</p><p>Another compound identified in group one is formic acid. It is predicted to interact with at least three chorismate binding enzymes, an anthranilate synthase protein (SPRG_06062), and two hypothetical proteins (SPRG_12737 and SPRG_16397). The antimicrobial activity of formic acid has been reported on various bacterial and yeast pathogens (<xref rid="ref70" ref-type="bibr">Plumed-Ferrer and von Wright, 2011</xref>; <xref rid="ref43" ref-type="bibr">Lastauskiene et al., 2014</xref>). However, chronic exposure to this molecule has been shown to have adverse health effects similar to those observed in methanol poisoning, i.e., metabolic acidosis and ocular toxicity (<xref rid="ref91" ref-type="bibr">Thompson, 1992</xref>).</p><p>&#x003b1;-Phosphoribosylpyrophosphoric acid is predicted to interact with two proteins of unknown functions and anthranilate phosphoribosyltransferase, which is involved in the biosynthesis of aromatic amino acids. This compound is a key intermediate of the biosynthesis of nucleotides and likely to interfere with other vital processes of the fish hosts. This suggests that it would not be suitable for the management of saprolegniasis.</p><p>In conclusion, the compounds from this first group of inhibitors are expected to lack specificity (e.g., citric acid) or to be inactive against <italic>Saprolegnia</italic> (e.g., echinocandins), and, in some cases, to have adverse health effects on the fish hosts or humans (e.g., formic acid). Thus, in order to select more specific inhibitors potentially usable against <italic>Saprolegnia</italic>, we have focused the rest of our study on molecules that are predicted to bind a single essential protein in the pathogen.</p></sec><sec id="sec11"><title>Compounds Interacting With a Single Protein From <italic>S. parasitica</italic> (Group 2)</title><p>This group comprises 31 compounds, the majority being sulfonamides or &#x0201c;sulfa drugs&#x0201d; (18 molecules). Sulfonamides are predicted to interact with the protein SPRG_19504 in <italic>S. parasitica</italic>, which belongs to the dihydropteroate synthase (DHPS) family and contains a 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase (HPPK) domain and a pterin-binding domain. In several bacteria and lower eukaryotes, HPPK (EC 2.7.6.3) and DHPS (EC 2.5.1.15) enzymes catalyze sequential reactions in the folic acid biosynthetic pathway (<xref rid="ref38" ref-type="bibr">Illarionova et al., 2002</xref>). Higher eukaryotes obtain folate from dietary sources and lack necessary enzymes for folate biosynthesis (<xref rid="ref53" ref-type="bibr">Matherly, 2001</xref>), whereas eubacteria and lower eukaryotes are able to synthesize tetrahydrofolate. Thus, the folate pathway is an interesting potential target for anti-infective agents. Indeed, DHPS is a well-known target of the sulfonamide class of antibacterial drugs (<xref rid="ref34" ref-type="bibr">Hevener et al., 2010</xref>). CDD analysis of the proteome of <italic>S. parasitica</italic> revealed the presence of two additional proteins involved in the last step of the folic acid biosynthetic pathway and annotated as dihydrofolate reductase (DHFR), i.e., SPRG_10565 and SPRG_17339. These observations suggest that sulfonamides are potential effective inhibitors of the growth of <italic>Saprolegnia</italic>.</p><p>Quaternary ammonium compounds like cetrimonium and didecyldimethylammonium are predicted to interact with SPRG_00820, a hypothetical protein that contains a mycolic acid cyclopropane synthetase domain. An antimycotic activity was reported for cetrimide, in particular, against fungal keratitis caused by <italic>Fusarium solani</italic>, without any negative effect on eye corneal tissues (<xref rid="ref49" ref-type="bibr">Mahmoud, 2007</xref>). Similarly, didecyldimethylammonium chloride (DDAC) is able to inactivate photosystem II (PSII) and disintegrate marine phytoplankton species (<xref rid="ref94" ref-type="bibr">van Slooten et al., 2015</xref>). It was also found effective against <italic>Escherichia coli</italic> where it induced the formation of blebs in the cell membrane, causing leakage of the intracellular compartment and subsequent cell death (<xref rid="ref102" ref-type="bibr">Yoshimatsu and Hiyama, 2007</xref>).</p><p>Triclosan and triclocarban are commonly used broad-spectrum antibacterial/antifungal agents that block fatty acid biosynthesis by inhibiting enoyl-ACP reductase (<xref rid="ref19" ref-type="bibr">Dhillon et al., 2015</xref>). Both molecules are predicted to interact with the protein SPRG_20215 in <italic>S. parasitica</italic>, an uncharacterized protein that is predicted to contain a short-chain dehydrogenase/reductase (SDR) domain. Triclosan has been found to be effective against various Gram-negative and Gram-positive bacteria, as well as <italic>Mycobacteria</italic> (<xref rid="ref77" ref-type="bibr">Schweizer, 2001</xref>) and <italic>Plasmodium falciparum</italic> (<xref rid="ref86" ref-type="bibr">Surolia and Surolia, 2001</xref>), where it targets dihydrofolate reductase (<xref rid="ref6" ref-type="bibr">Bilsland et al., 2018</xref>). This inhibitor is also active against the parasite <italic>Leishmania panamensis</italic> with no toxicity toward mammalian cells at concentrations as high as 200 &#x003bc;g/ml (<xref rid="ref65" ref-type="bibr">Otero et al., 2014</xref>).</p><p>The benzimidazoles albendazole and thiabendazole are predicted to interact with the protein SPRG_07119 which carries a FAD-binding domain and is structurally similar to fumarate reductase 2 (PDB 5GLG) from <italic>Saccharomyces cerevisiae</italic>. Benzimidazoles are commonly used as fungicides and anthelminthic drugs where they specifically inhibit microtubule assembly (<xref rid="ref18" ref-type="bibr">Davidse, 1986</xref>).</p><p>Two other approved compounds from group 2 are acetohydroxamic acid (<xref rid="ref62" ref-type="bibr">Ohta et al., 2001</xref>) and ecabet (<xref rid="ref80" ref-type="bibr">Shibata et al., 1997</xref>), which inhibit ureases. In <italic>Saprolegnia</italic>, both drugs are predicted to interact with the protein SPRG_06801, which is predicted to be a nickel-dependent amidohydrolase that catalyzes the decomposition of urea into carbamate and ammonia. As such, this catabolic reaction represents an important source of nitrogen in bacteria, fungi, and plants. Urease activity has been reported in <italic>Cryptococcus gattii</italic> (<xref rid="ref24" ref-type="bibr">Feder et al., 2015</xref>) and the recently discovered novel systemic fungal pathogen <italic>Emergomyces africanus</italic> (<xref rid="ref45" ref-type="bibr">Lerm et al., 2017</xref>). Urease is considered an essential enzyme and is explored as a target for the development of novel antibacterial agents (<xref rid="ref29" ref-type="bibr">Follmer, 2010</xref>). Our <italic>in silico</italic> proteome analysis suggests that <italic>S. parasitica</italic> contains urease and therefore that inhibitors of this enzyme are worth testing against the pathogen.</p><p>Azelaic acid is predicted to interact with SPRG_13682, a hypothetical protein with 5'-3' exonuclease activity, and an <italic>N</italic>-terminal resolvase-like domain. Azelaic acid has been found effective against various Gram-positive and Gram-negative bacterial pathogens by inhibiting several oxidoreductases and interfering with glycolysis (<xref rid="ref60" ref-type="bibr">Nazzaro-Porro, 1987</xref>).</p><p>Chloramphenicol was also identified in group 2. It is a common antibacterial agent that acts by inhibiting protein synthesis (<xref rid="ref100" ref-type="bibr">Xaplanteri et al., 2003</xref>) and is considered fungistatic (<xref rid="ref75" ref-type="bibr">Rooke and Shattock, 1983</xref>). It has been reported to exert variable inhibitory activity on the growth of <italic>Phytophthora</italic> species (<xref rid="ref67" ref-type="bibr">Panek and Tomsovsky, 2017</xref>). Indeed, resistant strains of <italic>Phytophthora</italic> have been reported (<xref rid="ref4" ref-type="bibr">Ann and Ko, 1992</xref>) alongside sensitive strains.</p><p>The last three compounds in group 2 are tromethamine, glycerol, and benzoic acid (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S3</xref>). Tromethamine is predicted to interact with the hypothetical protein SPRG_04175, which contains a biotin and thiamin synthesis associated domain. Glycerol is predicted to interact with a histidinol dehydrogenase (SPRG_01876) and it has been explored previously for its antibacterial activity (<xref rid="ref76" ref-type="bibr">Saegeman et al., 2008</xref>). Benzoic acid is a common food preservative used to prevent the growth of yeast and molds (<xref rid="ref11" ref-type="bibr">Brown and Swinburne, 1971</xref>). It most likely acts by interacting with the putative hydrolase SPRG_02663, a hypothetical Xaa-Pro dipeptidyl-peptidase with a <italic>C</italic>-terminal non-catalytic domain. This compound showed activity against various stages of fungal development (<xref rid="ref3" ref-type="bibr">Amborab&#x000e9; et al., 2002</xref>) and it has recently been reported to be effective against <italic>S. parasitica</italic> (<xref rid="ref90" ref-type="bibr">Tedesco et al., 2019</xref>), but its mechanism of inhibition was not investigated in these studies.</p><p>In conclusion, most of the inhibitors from group 2 have been shown to be effective against other microbial pathogens, which support the validity of our approach, but a large majority of these compounds have never been tested against <italic>Saprolegnia</italic>. Therefore, the next step of our work involved the use of <italic>in vitro</italic> assays in the presence of representative chemicals of the different classes from group 2 to determine whether these selected inhibitors affect the growth of <italic>S. parasitica</italic> and to which extent.</p></sec><sec id="sec12"><title>Effect of Selected Compounds on the Growth of <italic>S. parasitica</italic> in Liquid Medium</title><p>From the above list of DrugBank compounds predicted to interact with single proteins of <italic>S. parasitica</italic> (group 2), nine representative compounds were tested for their growth inhibitory effect on <italic>Saprolegnia</italic> mycelium (<xref rid="tab2" ref-type="table">Table 2</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>). In addition, copper sulfate, boric acid, and malachite green were used as positive controls, and the solvents of the different inhibitors were tested as negative controls (see Materials and Methods section). The solvents used for the preparation of stock solutions of the selected compounds, i.e., water, dimethyl sulfoxide (DMSO), ethanol, and acetone, did not inhibit the growth of <italic>S. parasitica</italic> at concentrations up to 1% v/v (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1A</xref>,<xref ref-type="supplementary-material" rid="SM1">B</xref>). These results are in keeping with previous reports (<xref rid="ref101" ref-type="bibr">Xue-Gang et al., 2013</xref>; <xref rid="ref35" ref-type="bibr">Hoskonen et al., 2015</xref>). However, some growth inhibition was observed with DMSO and ethanol at concentrations higher than 2% v/v, while growth was not perturbed in acetone at concentrations as high as 10% v/v.</p><p>Triclosan and triclocarban are predicted to target the protein SPRG_20215. Triclosan was found to be very effective when tested in liquid Machlis medium, with an MIC<sub>100</sub> concentration of 4 &#x003bc;g/ml (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1C</xref>), and significant levels of inhibition still observed at a lower concentration of 2 &#x003bc;g/ml. Benzoic acid (targeting the hypothetical protein SPRG_02663) and acetohydroxamic acid (targeting the putative urease SPRG_06801) arrested growth completely at 600 and 800 &#x003bc;g/ml, respectively. In addition, significant growth inhibition was still observed at lower concentrations (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1D</xref>,<xref ref-type="supplementary-material" rid="SM1">E</xref>). Recently, another group also reported benzoic acid as an effective compound against <italic>S. parasitica</italic> (<xref rid="ref90" ref-type="bibr">Tedesco et al., 2019</xref>). However, in our experimental conditions, the 100 &#x003bc;g/ml concentration tested by <xref rid="ref90" ref-type="bibr">Tedesco et al. (2019)</xref> had no visible effect on <italic>Saprolegnia</italic> growth (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1D</xref>). Other compounds such as the sulfonamide sulfamethoxazole (800 &#x003bc;g/ml), chloramphenicol (800 &#x003bc;g/ml), and azelaic acid (800 &#x003bc;g/ml) showed growth inhibition at less than 1,000 &#x003bc;g/ml (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1F</xref>,<xref ref-type="supplementary-material" rid="SM1">G</xref>,<xref ref-type="supplementary-material" rid="SM1">H</xref>). Furthermore, glycerol, albendazole, and thiabendazole did not show any significant inhibitory effect up to a concentration of 1,000 &#x003bc;g/ml (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1I</xref>,<xref ref-type="supplementary-material" rid="SM1">J</xref>,<xref ref-type="supplementary-material" rid="SM1">K</xref>). The compounds that significantly inhibited the growth of <italic>S. parasitica</italic> at concentrations lower than 1,000 &#x003bc;g/ml were considered effective, and their activity was further analyzed.</p><p>As expected and reported earlier, the positive controls, such as copper sulfate (400 &#x003bc;g/ml; <xref rid="ref85" ref-type="bibr">Sun et al., 2014</xref>), boric acid (400 &#x003bc;g/ml; <xref rid="ref2" ref-type="bibr">Ali et al., 2014</xref>), and malachite green (2 &#x003bc;g/ml; <xref rid="ref52" ref-type="bibr">Martin, 1968</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1L</xref>,<xref ref-type="supplementary-material" rid="SM1">M</xref>,<xref ref-type="supplementary-material" rid="SM1">N</xref>) arrested the growth of mycelium in the liquid medium of Machlis. However, the use of sesame seeds to inoculate the culture medium leads to variable amounts and quality of mycelium per cell culture well (<xref rid="ref84" ref-type="bibr">Stueland et al., 2005</xref>). This variability of inoculum size and quality is most likely responsible for the discrepancies reported in the literature with regard to the most efficient inhibitory concentrations of the different drugs.</p></sec><sec id="sec13"><title>Effect of the Selected Compounds on Radial Growth of <italic>S. parasitica</italic> on Solid Medium</title><p>To further evaluate the effect of the selected drugs on the growth of <italic>S. parasitica</italic> on a solid medium, we prepared PDA plates supplemented with the minimum inhibitory concentrations of each drug determined in the <italic>in vitro</italic> assays in liquid Machlis medium (<xref rid="tab2" ref-type="table">Table 2</xref>). As no growth was observed for any of the compounds tested, a lower (sub-inhibitory) concentration was used to test the effect of each inhibitor (<xref rid="tab2" ref-type="table">Table 2</xref>; <xref rid="fig2" ref-type="fig">Figure 2</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref>). As expected, normal growth was observed on PDA plates devoid of inhibitor. Similar to the observations in liquid medium (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>), no inhibition was observed in the presence of glycerol, albendazole, and thiabendazole (1,000 &#x003bc;g/ml each) after 72 h culture at 24&#x000b0;C (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S2K</xref>,<xref ref-type="supplementary-material" rid="SM1">L</xref>,<xref ref-type="supplementary-material" rid="SM1">M</xref>). Significant levels of inhibition were observed in the presence of triclosan (4 &#x003bc;g/ml), benzoic acid (400 &#x003bc;g/ml), acetohydroxamic acid (600 &#x003bc;g/ml), sulfamethoxazole (800 &#x003bc;g/ml), azelaic acid (1,000 &#x003bc;g/ml), chloramphenicol (800 &#x003bc;g/ml), copper sulfate (400 &#x003bc;g/ml), boric acid (400 &#x003bc;g/ml), and malachite green (0.8 &#x003bc;g/ml; <xref rid="fig2" ref-type="fig">Figure 2</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref>).</p></sec><sec id="sec14"><title>Effect of the Selected Compounds on the Morphology of <italic>S. parasitica</italic></title><p>Optical microscopy observations were made to analyze the effect of the selected inhibitors on the morphology of <italic>S. parasitica</italic> (<xref rid="fig3" ref-type="fig">Figure 3</xref>). In the absence of inhibitor, the hyphae appeared as translucent elongated cells. As opposed to the control, hyper-branching was commonly observed in the presence of some of the drugs that arrest the growth of the mycelium (<xref rid="fig3" ref-type="fig">Figure 3</xref>). The level of hyper-branching varied for the different compounds and was dose-dependent (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3</xref>). Pronounced hyper-branching was observed in the presence of triclosan (4 &#x003bc;g/ml), followed by benzoic acid (400 &#x003bc;g/ml), sulfamethoxazole (400 &#x003bc;g/ml), and boric acid (400 &#x003bc;g/ml). In the presence of acetohydroxamic acid, chloramphenicol, azelaic acid, and copper sulfate, low levels of side branching were visible (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Interestingly, compared to other strong inhibitors of growth, no pronounced hyper-branching was visible in the presence of malachite green (<xref rid="fig3" ref-type="fig">Figure 3J</xref>). Hyper-branching of the mycelium of <italic>S. parasitica</italic> in the presence of various inhibitors has not been explored previously. Therefore, an in-depth study of the mechanisms underlying the formation of such branching structures would be necessary to understand the effect of the inhibitors on cell development.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Optical microscopy observation of the effect of selected compounds on the growth of hyphae of <italic>S. parasitica</italic> after 24 h culture at 24&#x000b0;C in Machlis medium. <bold>(A)</bold> No Drug, <bold>(B)</bold> Triclosan (4 &#x003bc;g/ml), <bold>(C)</bold> Benzoic acid (400 &#x003bc;g/ml), <bold>(D)</bold> Acetohydroxamic acid (600 &#x003bc;g/ml), <bold>(E)</bold> Sulfamethoxazole (400 &#x003bc;g/ml), <bold>(F)</bold> Chloramphenicol (800 &#x003bc;g/ml), <bold>(G)</bold> Azelaic acid (800 &#x003bc;g/ml), <bold>(H)</bold> Copper sulfate (200 &#x003bc;g/ml), <bold>(I)</bold> Boric acid (400 &#x003bc;g/ml), and <bold>(J)</bold> Malachite green (0.8 &#x003bc;g/ml). Scale bars = 100 &#x003bc;m.</p></caption><graphic xlink:href="fmicb-11-571093-g003"/></fig></sec><sec id="sec15"><title>Homology Modeling and Docking</title><p>In this work, homology modeling and <italic>in silico</italic> docking studies were performed to better understand the mode of interaction between proteins and inhibitors. To this end, we used the six compounds shown to be effective in the <italic>in vitro</italic> assays along with their respective predicted target proteins (<xref rid="fig4" ref-type="fig">Figure 4</xref>; <xref ref-type="supplementary-material" rid="SM2">Supplementary Table S4</xref>). The six target proteins were SPRG_20215, SPRG_02663, SPRG_06801, SPRG_19504, SPRG_35021, and SPRG_13682. The 3D template structure for each of the selected proteins and corresponding percent sequence identity are presented in <xref ref-type="supplementary-material" rid="SM2">Supplementary Table S4</xref>. All proteins had a significantly high sequence identity of &#x0003e;30%, which allowed the generation of a reliable 3D protein structure, except for SPRG_02663, which has a slightly lower sequence identity (25.5%) with its template protein. The docking results show an approximate binding pattern of the inhibitors with their target proteins. Analysis of the docked complexes (compounds with their respective proteins) showed a considerable number of hydrogen bonding within the protein cavity or the active sites, which supports the specificity of the binding of each inhibitor with its respective protein. Furthermore, all the compounds showed significantly high binding energy toward their target, ranging from &#x02212;7.7 to &#x02212;4.4 kcal mol<sup>&#x02212;1</sup>, which indicates strong interactions between the ligands and their targets (<xref rid="fig4" ref-type="fig">Figure 4</xref>; <xref ref-type="supplementary-material" rid="SM2">Supplementary Table S4</xref>).</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Homology modeling and docking of the tested compounds with their respective target proteins. For each of the protein-ligand complexes, the LigPlot cartoons show the interactions between each inhibitor and the amino acid residues in the active site cleft of the respective proteins. <bold>(A)</bold> SPRG_20215 with triclosan (DB08604; binding energy &#x02212;7.5 kcal/mol), <bold>(B)</bold> SPRG_02663 with benzoic acid (DB03793; binding energy &#x02212;5.7 kcal/mol), <bold>(C)</bold> SPRG_06801 (putative urease) with acetohydroxamic acid (DB00551; binding energy &#x02212;4.4 kcal/mol), <bold>(D)</bold> SPRG_19504 with sulfamethoxazole (DB01015; binding energy &#x02212;4 kcal/mol), <bold>(E)</bold> SPRG_35021 with chloramphenicol (DB00446; binding energy &#x02212;7.7 kcal/mol), and <bold>(F)</bold> SPRG_13682 with azelaic acid (DB00548; binding energy &#x02212;5.0 kcal/mol).</p></caption><graphic xlink:href="fmicb-11-571093-g004"/></fig><p>The results of the virtual screening were visualized using LigPlot to show the details of the interactions of the proteins with their respective ligands (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Triclosan (DB08604), which is predicted to bind to the uncharacterized protein SPRG_20215, interacts through a single H bond between the O5 atom of the drug and the backbone amino group of Leu23. In addition, there are 13 residues from the protein that contribute to hydrophobic interactions. Similar interacting residues have been reported earlier for an enoyl-acyl carrier protein reductase from <italic>Thermus thermophilus</italic> (<xref rid="ref64" ref-type="bibr">Otero et al., 2012</xref>). The binding of benzoic acid (DB03793) to SPRG_02663 involves essentially hydrophobic interactions and a single H bond only. The SPRG_19504 protein complex with sulfamethoxazole (DB01015) involves seven amino acid residues from the protein that interact with the inhibitor through hydrophobic bonds while four residues are involved in H bonds. The interaction between SPRG_13682 and azelaic acid (DB00548) shows that the inhibitor interacts within the core hydrophobic pocket of the protein, with six hydrophobic residues involved in addition to the four H bonds associated with two polar and one negatively charged residues of the protein. Chloramphenicol (DB00446) interacts with SPRG_35021 through four H bonds while three other residues from the protein are engaged in hydrophobic interactions. The smallest inhibitor analyzed, acetohydroxamic acid (DB00551), forms H bonds with charged residues like His, Asp, and Lys, and it also interacts through hydrophobic bonds with five surrounding residues of the putative urease protein SPRG_06801. In summary, the docking study reveals that all complexes analyzed involve H bonding and hydrophobic interactions; it supports the initial screening results and provides initial evidence for the likely mechanisms of action of the six drug-proteins pairs identified in this work.</p><p>We have identified several compounds along with their probable target proteins using a subtractive proteomics approach and tested nine of these molecules <italic>in vitro</italic> for their efficacy against the growth of <italic>S. parasitica&#x02019;s</italic> mycelium. Molecular docking studies showed that these compounds exhibit minimum binding energies to their respective targets and present a strong affinity toward the active pockets of the proteins, which further supports the experimentally observed growth inhibition. Considering both the low effective concentration of some of these compounds against <italic>Saprolegnia</italic> and the fact that they are already used in humans suggest that they would be safe to use in aquaculture. Moreover, the concentration of triclosan effective against <italic>Saprolegnia</italic> under our <italic>in vitro</italic> conditions (4 &#x003bc;g/ml) is significantly lower to its &#x0201c;no-observed-adverse-effect level&#x0201d; (NOAEL) in humans (0.3% w/w; <xref rid="ref44" ref-type="bibr">Lee et al., 2019</xref>). Similarly, acetohydroxamic acid, which is effective against <italic>S. parasitica</italic> at around 600&#x02013;800 &#x003bc;g/ml, is used at up to 15 mg/kg/day for the treatment of human urinary infections and stones (<xref rid="ref32" ref-type="bibr">Griffith et al., 1981</xref>; <xref rid="ref97" ref-type="bibr">Williams et al., 1984</xref>). Azelaic acid (600&#x02013;800 &#x003bc;g/ml against <italic>S. parasitica</italic>) has not shown any toxic effect during oral (&#x02264;20 g/day) or topical (20% cream) administration to humans (<xref rid="ref27" ref-type="bibr">Fitton and Goa, 1991</xref>). Both sulfamethoxazole and chloramphenicol have been widely used as antibacterial agents in humans and animals. Sulfamethoxazole (800 &#x003bc;g/ml against <italic>S. parasitica</italic>) has been used in combination with trimethoprim for over 30 years, with a recommended dosage of up to 40 mg/kg/12 h (<xref rid="ref22" ref-type="bibr">Dudley et al., 1984</xref>). Similarly, also effective at 800 &#x003bc;g/ml against <italic>S. parasitica</italic>, chloramphenicol has a recommended dosage of 25 mg/kg/6 h (<xref rid="ref72" ref-type="bibr">Powell and Nahata, 1982</xref>). Future work is required to confirm the probable mechanism of action of these promising compounds as well as their efficacy on the different developmental stages of <italic>S. parasitica</italic> (<xref rid="ref82" ref-type="bibr">Srivastava et al., 2018</xref>). It may also become possible to increase their efficacy by downstream modification and make them usable for the treatment of saprolegniasis in fish eggs, juvenile, and adult fish. Furthermore, the current integrative approach is not limited to saprolegniasis but it can also be employed for the identification of potential inhibitors of other oomycete pathogens.</p></sec></sec><sec sec-type="data-availability" id="sec16"><title>Data Availability Statement</title><p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="sec19">Supplementary Material</xref>.</p></sec><sec id="sec17"><title>Author Contributions</title><p>SK, VB, and VS designed the experimental work, analyzed the data and wrote the manuscript. RM contributed to the molecular modeling experiments. All authors contributed to the article and approved the submitted version.</p><sec id="sec18" sec-type="coi"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grants to VB from the European Commission (Horizon 2020 FET-OPEN Grant Agreement No. 828940) and to VS from the Swedish Research Council FORMAS (grant #2019-00912).</p></fn></fn-group><fn-group><fn id="fn001"><p><sup>1</sup><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/genome">www.ncbi.nlm.nih.gov/genome</ext-link></p></fn></fn-group><sec id="sec19" sec-type="supplementary-material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2020.571093/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2020.571093/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Data_Sheet_1.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="SM2"><media xlink:href="Data_Sheet_2.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acar</surname><given-names>&#x000dc;.</given-names></name><name><surname>&#x00130;nanan</surname><given-names>B. E.</given-names></name><name><surname>Zemheri</surname><given-names>F.</given-names></name><name><surname>Kesbi&#x000e7;</surname><given-names>O. S.</given-names></name><name><surname>Y&#x00131;lmaz</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Acute exposure to boron in Nile tilapia (<italic>Oreochromis niloticus</italic>): median-lethal concentration (LC50), blood parameters, DNA fragmentation of blood and sperm cells</article-title>. <source>Chemosphere</source>
<volume>213</volume>, <fpage>345</fpage>&#x02013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1016/j.chemosphere.2018.09.063</pub-id>, PMID: <?supplied-pmid 30241078?><pub-id pub-id-type="pmid">30241078</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>S. E.</given-names></name><name><surname>Thoen</surname><given-names>E.</given-names></name><name><surname>Evensen</surname><given-names>O.</given-names></name><name><surname>Skaar</surname><given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Boric acid inhibits germination and colonization of <italic>Saprolegnia</italic> spores in vitro and in vivo</article-title>. <source>PLoS One</source>
<volume>9</volume>:<fpage>e91878</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0091878</pub-id>, PMID: <?supplied-pmid 24699283?><pub-id pub-id-type="pmid">24699283</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amborab&#x000e9;</surname><given-names>B. -E.</given-names></name><name><surname>Fleurat-Lessard</surname><given-names>P.</given-names></name><name><surname>Chollet</surname><given-names>J. -F.</given-names></name><name><surname>Roblin</surname><given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>Antifungal effects of salicylic acid and other benzoic acid derivatives towards Eutypa lata: structure-activity relationship</article-title>. <source>Plant Physiol. Biochem.</source>
<volume>40</volume>, <fpage>1051</fpage>&#x02013;<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1016/s0981-9428(02)01470-5</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ann</surname><given-names>P.</given-names></name><name><surname>Ko</surname><given-names>W.</given-names></name></person-group> (<year>1992</year>). <article-title>Survey of antibiotic resistance and dependence in Phytophthora</article-title>. <source>Mycologia</source>
<volume>84</volume>, <fpage>82</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.2307/3760405</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhardwaj</surname><given-names>T.</given-names></name><name><surname>Haque</surname><given-names>S.</given-names></name><name><surname>Somvanshi</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Comparative assessment of the therapeutic drug targets of <italic>C. botulinum</italic> ATCC 3502 and <italic>C. difficile</italic> str. 630 using in silico subtractive proteomics approach</article-title>. <source>J. Cell. Biochem.</source>
<volume>120</volume>, <fpage>16160</fpage>&#x02013;<lpage>16184</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.28897</pub-id>, PMID: <?supplied-pmid 31081164?><pub-id pub-id-type="pmid">31081164</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilsland</surname><given-names>E.</given-names></name><name><surname>van Vliet</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>K.</given-names></name><name><surname>Feltham</surname><given-names>J.</given-names></name><name><surname>Carrasco</surname><given-names>M. P.</given-names></name><name><surname>Fotoran</surname><given-names>W. L.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan</article-title>. <source>Sci. Rep.</source>
<volume>8</volume>:<fpage>1038</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-19549-x</pub-id>, PMID: <?supplied-pmid 29348637?><pub-id pub-id-type="pmid">29348637</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Biovia</surname><given-names>D. S.</given-names></name></person-group> (<year>2018</year>). &#x0201c;Discovery Studio, 2.5.&#x0201d; Dassault Syst&#x000e8;mes San Diego.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaustein</surname><given-names>A. R.</given-names></name><name><surname>Hokit</surname><given-names>D. G.</given-names></name><name><surname>O&#x02019;Hara</surname><given-names>R. K.</given-names></name><name><surname>Holt</surname><given-names>R. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Pathogenic fungus contributes to amphibian losses in the Pacific northwest</article-title>. <source>Biol. Conserv.</source>
<volume>67</volume>, <fpage>251</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/0006-3207(94)90616-5</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bly</surname><given-names>J.</given-names></name><name><surname>Quiniou</surname><given-names>S.</given-names></name><name><surname>Lawson</surname><given-names>L.</given-names></name><name><surname>Clem</surname><given-names>L.</given-names></name></person-group> (<year>1996</year>). <article-title>Therapeutic and prophylactic measures for winter saprolegniosis in channel catfish</article-title>. <source>Dis. Aquat. Org.</source>
<volume>24</volume>, <fpage>25</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.3354/dao024025</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branson</surname><given-names>E.</given-names></name></person-group> (<year>2002</year>). <article-title>Efficacy of bronopol against infection of rainbow trout (<italic>Oncorhynchus mykiss</italic>) with the fungus <italic>Saprolegnia</italic> species</article-title>. <source>Vet. Rec.</source>
<volume>151</volume>, <fpage>539</fpage>&#x02013;<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1136/vr.151.18.539</pub-id>, PMID: <?supplied-pmid 12448491?><pub-id pub-id-type="pmid">12448491</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A. E.</given-names></name><name><surname>Swinburne</surname><given-names>T.</given-names></name></person-group> (<year>1971</year>). <article-title>Benzoic acid: an antifungal compound formed in Bramley&#x02019;s seedling apple fruits following infection by Nectria galligena Bres</article-title>. <source>Physiol. Plant Pathol.</source>
<volume>1</volume>, <fpage>469</fpage>&#x02013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1016/0048-4059(71)90009-9</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Bulone</surname><given-names>V.</given-names></name></person-group> (<year>1992</year>). Etude des glycanes pari&#x000e9;taux de <italic>Saprolegnia</italic> monoica et caract&#x000e9;risation biochimique et immunologique de leurs enzymes de synth&#x000e8;se. PhD thesis. Villeurbanne, France: University of Lyon.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulone</surname><given-names>V.</given-names></name><name><surname>F&#x000e8;vre</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>A 34-kilodalton polypeptide is associated with 1,3-beta-glucan synthase activity from the fungus <italic>Saprolegnia monoica</italic></article-title>. <source>FEMS Microbiol. Lett.</source>
<volume>140</volume>, <fpage>145</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1996.tb08328.x</pub-id>, PMID: <?supplied-pmid 8764476?><pub-id pub-id-type="pmid">8764476</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulone</surname><given-names>V.</given-names></name><name><surname>Girard</surname><given-names>V.</given-names></name><name><surname>Fevre</surname><given-names>M.</given-names></name></person-group> (<year>1990</year>). <article-title>Separation and partial purification of 1,3-beta-glucan and 1,4-&#x003b2;-Glucan synthases from <italic>Saprolegnia</italic></article-title>. <source>Plant Physiol.</source>
<volume>94</volume>, <fpage>1748</fpage>&#x02013;<lpage>1755</lpage>. <pub-id pub-id-type="doi">10.1104/pp.94.4.1748</pub-id>, PMID: <?supplied-pmid 16667912?><pub-id pub-id-type="pmid">16667912</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesur</surname><given-names>M. F.</given-names></name><name><surname>Siraj</surname><given-names>B.</given-names></name><name><surname>Uddin</surname><given-names>R.</given-names></name><name><surname>Durmu&#x0015f;</surname><given-names>S.</given-names></name><name><surname>&#x000c7;ak&#x00131;r</surname><given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Network-based metabolism-centered screening of potential drug targets in <italic>Klebsiella pneumoniae</italic> at genome scale</article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>9</volume>:<fpage>447</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2019.00447</pub-id>, PMID: <?supplied-pmid 31993376?><pub-id pub-id-type="pmid">31993376</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Dallakyan</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). PyRx-python prescription v. 0.8. The Scripps Research Institute 2010.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S. K.</given-names></name><name><surname>Murmu</surname><given-names>K.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Shakuntala</surname><given-names>I.</given-names></name><name><surname>Das</surname><given-names>R. K.</given-names></name><name><surname>Ngachan</surname><given-names>S. V.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Studies on the identification and control of pathogen <italic>Saprolegnia</italic> in selected Indian major carp fingerlings at mid hill altitude</article-title>. <source>J. Environ. Biol.</source>
<volume>33</volume>, <fpage>545</fpage>&#x02013;<lpage>549</lpage>. PMID: <?supplied-pmid 23029901?><pub-id pub-id-type="pmid">23029901</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidse</surname><given-names>L. C.</given-names></name></person-group> (<year>1986</year>). <article-title>Benzimidazole fungicides: mechanism of action and biological impact</article-title>. <source>Annu. Rev. Phytopathol.</source>
<volume>24</volume>, <fpage>43</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.py.24.090186.000355</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhillon</surname><given-names>G. S.</given-names></name><name><surname>Kaur</surname><given-names>S.</given-names></name><name><surname>Pulicharla</surname><given-names>R.</given-names></name><name><surname>Brar</surname><given-names>S. K.</given-names></name><name><surname>Cledon</surname><given-names>M.</given-names></name><name><surname>Verma</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Triclosan: current status, occurrence, environmental risks and bioaccumulation potential</article-title>. <source>Int. J. Environ. Res. Public Health</source>
<volume>12</volume>, <fpage>5657</fpage>&#x02013;<lpage>5684</lpage>. <pub-id pub-id-type="doi">10.3390/ijerph120505657</pub-id>, PMID: <?supplied-pmid 26006133?><pub-id pub-id-type="pmid">26006133</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di&#x000e9;guez-Uribeondo</surname><given-names>J.</given-names></name><name><surname>Cerenius</surname><given-names>L.</given-names></name><name><surname>S&#x000f6;derh&#x000e4;ll</surname><given-names>K.</given-names></name></person-group> (<year>1994</year>). <article-title><italic>Saprolegnia parasitica</italic> and its virulence on three different species of freshwater crayfish</article-title>. <source>Aquaculture</source>
<volume>120</volume>, <fpage>219</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/0044-8486(94)90080-9</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donovan</surname><given-names>M.</given-names></name><name><surname>Schumuke</surname><given-names>J. J.</given-names></name><name><surname>Fonzi</surname><given-names>W. A.</given-names></name><name><surname>Bonar</surname><given-names>S. L.</given-names></name><name><surname>Gheesling-Mullis</surname><given-names>K.</given-names></name><name><surname>Jacob</surname><given-names>G. S.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Virulence of a phosphoribosylaminoimidazole carboxylase-deficient <italic>Candida albicans</italic> strain in an immunosuppressed murine model of systemic candidiasis</article-title>. <source>Infect. Immun.</source>
<volume>69</volume>, <fpage>2542</fpage>&#x02013;<lpage>2548</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.4.2542-2548.2001</pub-id>, PMID: <?supplied-pmid 11254618?><pub-id pub-id-type="pmid">11254618</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname><given-names>M. N.</given-names></name><name><surname>Levitz</surname><given-names>R.</given-names></name><name><surname>Quintiliani</surname><given-names>R.</given-names></name><name><surname>Hickingbotham</surname><given-names>J.</given-names></name><name><surname>Nightingale</surname><given-names>C.</given-names></name></person-group> (<year>1984</year>). <article-title>Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>26</volume>, <fpage>811</fpage>&#x02013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.26.6.811</pub-id>, PMID: <?supplied-pmid 6335381?><pub-id pub-id-type="pmid">6335381</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Romero</surname><given-names>M. R.</given-names></name><name><surname>Wolf</surname><given-names>D. G.</given-names></name><name><surname>Stamminger</surname><given-names>T.</given-names></name><name><surname>Marin</surname><given-names>J. J.</given-names></name><name><surname>Marschall</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>The antiviral activities of artemisinin and artesunate</article-title>. <source>Clin. Infect. Dis.</source>
<volume>47</volume>, <fpage>804</fpage>&#x02013;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1086/591195</pub-id>, PMID: <?supplied-pmid 18699744?><pub-id pub-id-type="pmid">18699744</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feder</surname><given-names>V.</given-names></name><name><surname>Kmetzsch</surname><given-names>L.</given-names></name><name><surname>Staats</surname><given-names>C. C.</given-names></name><name><surname>Vidal-Figueiredo</surname><given-names>N.</given-names></name><name><surname>Ligabue-Braun</surname><given-names>R.</given-names></name><name><surname>Carlini</surname><given-names>C. R.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Cryptococcus gattii urease as a virulence factor and the relevance of enzymatic activity in cryptococcosis pathogenesis</article-title>. <source>FEBS J.</source>
<volume>282</volume>, <fpage>1406</fpage>&#x02013;<lpage>1418</lpage>. <pub-id pub-id-type="doi">10.1111/febs.13229</pub-id>, PMID: <?supplied-pmid 25675897?><pub-id pub-id-type="pmid">25675897</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Beneitez</surname><given-names>M. J.</given-names></name><name><surname>Ortiz-Santaliestra</surname><given-names>M. E.</given-names></name><name><surname>Lizana</surname><given-names>M.</given-names></name><name><surname>Dieguez-Uribeondo</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Differences in susceptibility to <italic>Saprolegnia</italic> infections among embryonic stages of two anuran species</article-title>. <source>Oecologia</source>
<volume>165</volume>, <fpage>819</fpage>&#x02013;<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1007/s00442-010-1889-5</pub-id>, PMID: <?supplied-pmid 21197546?><pub-id pub-id-type="pmid">21197546</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finn</surname><given-names>R. D.</given-names></name><name><surname>Coggill</surname><given-names>P.</given-names></name><name><surname>Eberhardt</surname><given-names>R. Y.</given-names></name><name><surname>Eddy</surname><given-names>S. R.</given-names></name><name><surname>Mistry</surname><given-names>J.</given-names></name><name><surname>Mitchell</surname><given-names>A. L.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>The Pfam protein families database: towards a more sustainable future</article-title>. <source>Nucleic Acids Res.</source>
<volume>44</volume>, <fpage>D279</fpage>&#x02013;<lpage>D285</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1344</pub-id>, PMID: <?supplied-pmid 26673716?><pub-id pub-id-type="pmid">26673716</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitton</surname><given-names>A.</given-names></name><name><surname>Goa</surname><given-names>K. L.</given-names></name></person-group> (<year>1991</year>). <article-title>Azelaic acid: a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders</article-title>. <source>Drugs</source>
<volume>41</volume>, <fpage>780</fpage>&#x02013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.2165/00003495-199141050-00007</pub-id>, PMID: <?supplied-pmid 1712709?><pub-id pub-id-type="pmid">1712709</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>S.</given-names></name><name><surname>Montenegro</surname><given-names>I.</given-names></name><name><surname>Villena</surname><given-names>J.</given-names></name><name><surname>Cuellar</surname><given-names>M.</given-names></name><name><surname>Werner</surname><given-names>E.</given-names></name><name><surname>Godoy</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Synthesis and evaluation of novel oxyalkylated derivatives of 2',4'-dihydroxychalcone as anti-oomycete agents against bronopol resistant strains of <italic>Saprolegnia</italic> sp.</article-title>
<source>Int. J. Mol. Sci.</source>
<volume>17</volume>:<fpage>1366</fpage>. <pub-id pub-id-type="doi">10.3390/ijms17081366</pub-id>, PMID: <?supplied-pmid 27556457?><pub-id pub-id-type="pmid">27556457</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Follmer</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Ureases as a target for the treatment of gastric and urinary infections</article-title>. <source>J. Clin. Pathol.</source>
<volume>63</volume>, <fpage>424</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1136/jcp.2009.072595</pub-id>, PMID: <?supplied-pmid 20418234?><pub-id pub-id-type="pmid">20418234</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gieseker</surname><given-names>C.</given-names></name><name><surname>Serfling</surname><given-names>S.</given-names></name><name><surname>Reimschuessel</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Formalin treatment to reduce mortality associated with <italic>Saprolegnia parasitica</italic> in rainbow trout, <italic>Oncorhynchus mykiss</italic></article-title>. <source>Aquaculture</source>
<volume>253</volume>, <fpage>120</fpage>&#x02013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.aquaculture.2005.07.039</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-Alonso</surname><given-names>S.</given-names></name><name><surname>Jauregizar</surname><given-names>N.</given-names></name><name><surname>Canton</surname><given-names>E.</given-names></name><name><surname>Eraso</surname><given-names>E.</given-names></name><name><surname>Quindos</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against <italic>Candida glabrata</italic>, <italic>Candida bracarensis</italic>, and <italic>Candida nivariensis</italic> evaluated by time-kill studies</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>59</volume>, <fpage>3615</fpage>&#x02013;<lpage>3618</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.04474-14</pub-id>, PMID: <?supplied-pmid 25801575?><pub-id pub-id-type="pmid">25801575</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>D. P.</given-names></name><name><surname>Moskowitz</surname><given-names>P.</given-names></name><name><surname>Feldman</surname><given-names>S.</given-names></name></person-group> (<year>1981</year>). &#x0201c;<article-title>Infection-induced stones: status of clinic trials with Urostat&#x02122; (acetohydroxamic acid)</article-title>&#x0201d; in <source>Urolithiasis</source>. eds. <person-group person-group-type="editor"><name><surname>Smith</surname><given-names>L. H.</given-names></name><name><surname>Robertson</surname><given-names>W. G.</given-names></name><name><surname>Finlayson</surname><given-names>B.</given-names></name></person-group> (<publisher-loc>Boston, MA</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>199</fpage>&#x02013;<lpage>208</lpage>.</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerriero</surname><given-names>G.</given-names></name><name><surname>Avino</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Fugelstad</surname><given-names>J.</given-names></name><name><surname>Clergeot</surname><given-names>P. H.</given-names></name><name><surname>Bulone</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Chitin synthases from <italic>Saprolegnia</italic> are involved in tip growth and represent a potential target for anti-oomycete drugs</article-title>. <source>PLoS Pathog.</source>
<volume>6</volume>:<fpage>e1001070</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1001070</pub-id>, PMID: <?supplied-pmid 20865175?><pub-id pub-id-type="pmid">20865175</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hevener</surname><given-names>K. E.</given-names></name><name><surname>Yun</surname><given-names>M. K.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Kerr</surname><given-names>I. D.</given-names></name><name><surname>Babaoglu</surname><given-names>K.</given-names></name><name><surname>Hurdle</surname><given-names>J. G.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Structural studies of pterin-based inhibitors of dihydropteroate synthase</article-title>. <source>J. Med. Chem.</source>
<volume>53</volume>, <fpage>166</fpage>&#x02013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1021/jm900861d</pub-id>, PMID: <?supplied-pmid 19899766?><pub-id pub-id-type="pmid">19899766</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskonen</surname><given-names>P.</given-names></name><name><surname>Heikkinen</surname><given-names>J.</given-names></name><name><surname>Eskelinen</surname><given-names>P.</given-names></name><name><surname>Pirhonen</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Efficacy of clove oil and ethanol against <italic>Saprolegnia</italic> sp. and usability as antifungal agents during incubation of rainbow trout <italic>Oncorhynchus mykiss</italic> (Walbaum) eggs</article-title>. <source>Aquac. Res.</source>
<volume>46</volume>, <fpage>581</fpage>&#x02013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1111/are.12200</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>G. E.</given-names></name><name><surname>Gingerich</surname><given-names>W. H.</given-names></name><name><surname>Dawson</surname><given-names>V. K.</given-names></name><name><surname>Olson</surname><given-names>J. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Efficacy of hydrogen peroxide for treating saprolegniasis in channel catfish</article-title>. <source>J. Aquat. Anim. Health</source>
<volume>11</volume>, <fpage>222</fpage>&#x02013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1577/1548-8667(1999)011&#x0003c;0222:EOHPFT&#x0003e;2.0.CO;2</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>K.</given-names></name><name><surname>Ma</surname><given-names>R. R.</given-names></name><name><surname>Cheng</surname><given-names>J. M.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Yuan</surname><given-names>H. L.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Analysis of <italic>Saprolegnia parasitica</italic> transcriptome following treatment with copper sulfate</article-title>. <source>PLoS One</source>
<volume>11</volume>:<fpage>e0147445</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0147445</pub-id>, PMID: <?supplied-pmid 26895329?><pub-id pub-id-type="pmid">26895329</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illarionova</surname><given-names>V.</given-names></name><name><surname>Eisenreich</surname><given-names>W.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Haussmann</surname><given-names>C.</given-names></name><name><surname>Romisch</surname><given-names>W.</given-names></name><name><surname>Richter</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Biosynthesis of tetrahydrofolate. Stereochemistry of dihydroneopterin aldolase</article-title>. <source>J. Biol. Chem.</source>
<volume>277</volume>, <fpage>28841</fpage>&#x02013;<lpage>28847</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M204046200</pub-id>, PMID: <?supplied-pmid 12039964?><pub-id pub-id-type="pmid">12039964</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>F. H.</given-names></name><name><surname>Adoubi</surname><given-names>I.</given-names></name><name><surname>Comoe</surname><given-names>J. C. K.</given-names></name><name><surname>de Cnodder</surname><given-names>T.</given-names></name><name><surname>Jansen</surname><given-names>N.</given-names></name><name><surname>Tschulakow</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers</article-title>. <source>Anticancer Res.</source>
<volume>31</volume>, <fpage>4417</fpage>&#x02013;<lpage>4422</lpage>. PMID: <?supplied-pmid 22199309?><pub-id pub-id-type="pmid">22199309</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>T. H.</given-names></name><name><surname>Pichota</surname><given-names>A.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name></person-group> (<year>2006</year>). <article-title>A practical view of &#x02018;druggability&#x02019;</article-title>. <source>Curr. Opin. Chem. Biol.</source>
<volume>10</volume>, <fpage>357</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2006.06.014</pub-id>, PMID: <?supplied-pmid 16814592?><pub-id pub-id-type="pmid">16814592</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodabandeh</surname><given-names>S.</given-names></name><name><surname>Abtahi</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Effects of sodium chloride, formalin and iodine on the hatching success of common carp, <italic>Cyprinus carpio</italic>, eggs</article-title>. <source>J. Appl. Ichthyol.</source>
<volume>22</volume>, <fpage>54</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1111/j.1439-0426.2006.00662.x</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>R. A.</given-names></name><name><surname>Swindells</surname><given-names>M. B.</given-names></name></person-group> (<year>2011</year>). <article-title>LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>51</volume>, <fpage>2778</fpage>&#x02013;<lpage>2786</lpage>. <pub-id pub-id-type="doi">10.1021/ci200227u</pub-id>, PMID: <?supplied-pmid 21919503?><pub-id pub-id-type="pmid">21919503</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lastauskiene</surname><given-names>E.</given-names></name><name><surname>Zinkeviciene</surname><given-names>A.</given-names></name><name><surname>Girkontaite</surname><given-names>I.</given-names></name><name><surname>Kaunietis</surname><given-names>A.</given-names></name><name><surname>Kvedariene</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>Formic acid and acetic acid induce a programmed cell death in pathogenic Candida species</article-title>. <source>Curr. Microbiol.</source>
<volume>69</volume>, <fpage>303</fpage>&#x02013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-014-0585-9</pub-id>, PMID: <?supplied-pmid 24752490?><pub-id pub-id-type="pmid">24752490</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. D.</given-names></name><name><surname>Lee</surname><given-names>J. Y.</given-names></name><name><surname>Kwack</surname><given-names>S. J.</given-names></name><name><surname>Shin</surname><given-names>C. Y.</given-names></name><name><surname>Jang</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>H. Y.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Risk assessment of Triclosan, a cosmetic preservative</article-title>. <source>Toxicol. Res.</source>
<volume>35</volume>, <fpage>137</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.5487/TR.2019.35.2.137</pub-id>, PMID: <?supplied-pmid 31015896?><pub-id pub-id-type="pmid">31015896</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerm</surname><given-names>B.</given-names></name><name><surname>Kenyon</surname><given-names>C.</given-names></name><name><surname>Schwartz</surname><given-names>I. S.</given-names></name><name><surname>Kroukamp</surname><given-names>H.</given-names></name><name><surname>de Witt</surname><given-names>R.</given-names></name><name><surname>Govender</surname><given-names>N. P.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>First report of urease activity in the novel systemic fungal pathogen Emergomyces africanus: a comparison with the neurotrope <italic>Cryptococcus neoformans</italic></article-title>. <source>FEMS Yeast Res.</source>
<volume>17</volume>:<fpage>fox069</fpage>. <pub-id pub-id-type="doi">10.1093/femsyr/fox069</pub-id>, PMID: <?supplied-pmid 28934415?><pub-id pub-id-type="pmid">28934415</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>Y. F.</given-names></name><name><surname>Liu</surname><given-names>G. L.</given-names></name><name><surname>Ling</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>X. Y.</given-names></name><name><surname>Hu</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Inhibition of dioscin on <italic>Saprolegnia</italic> in vitro</article-title>. <source>FEMS Microbiol. Lett.</source>
<volume>362</volume>:<fpage>fnv196</fpage>. <pub-id pub-id-type="doi">10.1093/femsle/fnv196</pub-id>, PMID: <?supplied-pmid 26472687?><pub-id pub-id-type="pmid">26472687</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>C. T.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements</article-title>. <source>Nucleic Acids Res.</source>
<volume>42</volume>, <fpage>D574</fpage>&#x02013;<lpage>D580</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1131</pub-id>, PMID: <?supplied-pmid 24243843?><pub-id pub-id-type="pmid">24243843</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machlis</surname><given-names>L.</given-names></name></person-group> (<year>1953</year>). <article-title>Growth and nutrition of water molds in the subgenus Euallomyces. II. Optimal composition of the minimal medium</article-title>. <source>Am. J. Bot.</source>
<volume>40</volume>, <fpage>450</fpage>&#x02013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1002/j.1537-2197.1953.tb06505.x</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>Y. A.</given-names></name></person-group> (<year>2007</year>). <article-title>In vitro and in vivo antifungal activity of cetrimide (cetyltrimethyl ammonium bromide) against fungal keratitis caused by <italic>Fusarium solani</italic></article-title>. <source>Mycoses</source>
<volume>50</volume>, <fpage>64</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1439-0507.2006.01313.x</pub-id>, PMID: <?supplied-pmid 17302751?><pub-id pub-id-type="pmid">17302751</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchand</surname><given-names>P. A.</given-names></name><name><surname>Phan</surname><given-names>T. M.</given-names></name><name><surname>Straus</surname><given-names>D. L.</given-names></name><name><surname>Farmer</surname><given-names>B. D.</given-names></name><name><surname>St&#x000fc;ber</surname><given-names>A.</given-names></name><name><surname>Meinelt</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Reduction of in vitro growth in flavobacterium columnare and <italic>Saprolegnia parasitica</italic> by products containing peracetic acid</article-title>. <source>Aquac. Res.</source>
<volume>43</volume>, <fpage>1861</fpage>&#x02013;<lpage>1866</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2109.2011.02995.x</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name><name><surname>Bo</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Lanczycki</surname><given-names>C. J.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>CDD/SPARCLE: functional classification of proteins via subfamily domain architectures</article-title>. <source>Nucleic Acids Res.</source>
<volume>45</volume>, <fpage>D200</fpage>&#x02013;<lpage>D203</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1129</pub-id>, PMID: <?supplied-pmid 27899674?><pub-id pub-id-type="pmid">27899674</pub-id></mixed-citation></ref><ref id="ref400"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marking</surname><given-names>L. L.</given-names></name><name><surname>Rach</surname><given-names>J. J.</given-names></name><name><surname>Schreier</surname><given-names>T. M.</given-names></name></person-group> (<year>1994</year>). <article-title>American fisheries society evaluation of antifungal agents for fish culture</article-title>. <source>Progress. Fish Cult.</source>
<volume>56</volume>, <fpage>225</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1577/1548-8640(1994)056&#x0003c;0225:AFSEOA&#x0003e;2.3.CO;2</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>R.</given-names></name></person-group> (<year>1968</year>). The effect of malchite green as a fungicide.</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matherly</surname><given-names>L. H.</given-names></name></person-group> (<year>2001</year>). <article-title>Molecular and cellular biology of the human reduced folate carrier</article-title>. <source>Prog. Nucleic Acid Res. Mol. Biol.</source>
<volume>67</volume>, <fpage>131</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/s0079-6603(01)67027-2</pub-id>, PMID: <?supplied-pmid 11525381?><pub-id pub-id-type="pmid">11525381</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e9;lida</surname><given-names>H.</given-names></name><name><surname>Sandoval-Sierra</surname><given-names>J. V.</given-names></name><name><surname>Dieguez-Uribeondo</surname><given-names>J.</given-names></name><name><surname>Bulone</surname><given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Analyses of extracellular carbohydrates in oomycetes unveil the existence of three different cell wall types</article-title>. <source>Eukaryot. Cell</source>
<volume>12</volume>, <fpage>194</fpage>&#x02013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1128/EC.00288-12</pub-id>, PMID: <?supplied-pmid 23204192?><pub-id pub-id-type="pmid">23204192</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>A.</given-names></name><name><surname>Collins</surname><given-names>C.</given-names></name></person-group> (<year>1997</year>). <article-title>Review of the therapeutic uses of hydrogen peroxide in fish production</article-title>. <source>Aquac. Mag.</source>
<volume>23</volume>, <fpage>74</fpage>&#x02013;<lpage>79</lpage>.</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustafa</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Assessment of hydrogen peroxide on histopathology and survival rate in common carp, <italic>Cyprinus carpio</italic> l. infected with saprolegniasis</article-title>. <source>Iraqi J. Agri. Sci.</source>
<volume>50</volume>, <fpage>697</fpage>&#x02013;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.36103/ijas.v2i50.669</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzzarelli</surname><given-names>R. A.</given-names></name><name><surname>Muzzarelli</surname><given-names>C.</given-names></name><name><surname>Tarsi</surname><given-names>R.</given-names></name><name><surname>Miliani</surname><given-names>M.</given-names></name><name><surname>Gabbanelli</surname><given-names>F.</given-names></name><name><surname>Cartolari</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Fungistatic activity of modified chitosans against <italic>Saprolegnia parasitica</italic></article-title>. <source>Biomacromolecules</source>
<volume>2</volume>, <fpage>165</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1021/bm000091s</pub-id>, PMID: <?supplied-pmid 11749168?><pub-id pub-id-type="pmid">11749168</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>K.</given-names></name><name><surname>Hara</surname><given-names>C.</given-names></name><name><surname>Tokuyama</surname><given-names>S.</given-names></name><name><surname>Takada</surname><given-names>K.</given-names></name><name><surname>Imamura</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Saprolmycins A-E, new angucycline antibiotics active against <italic>Saprolegnia parasitica</italic></article-title>. <source>J. Antibiot.</source>
<volume>65</volume>, <fpage>599</fpage>&#x02013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2012.86</pub-id>, PMID: <?supplied-pmid 23093030?><pub-id pub-id-type="pmid">23093030</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazzaro-Porro</surname><given-names>M.</given-names></name></person-group> (<year>1987</year>). <article-title>Azelaic acid</article-title>. <source>J. Am. Acad. Dermatol.</source>
<volume>17</volume>, <fpage>1033</fpage>&#x02013;<lpage>1041</lpage>. <pub-id pub-id-type="doi">10.1016/s0190-9622(87)70294-1</pub-id>, PMID: <?supplied-pmid 2963038?><pub-id pub-id-type="pmid">2963038</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>M.</given-names></name><name><surname>Lundegaard</surname><given-names>C.</given-names></name><name><surname>Lund</surname><given-names>O.</given-names></name><name><surname>Petersen</surname><given-names>T. N.</given-names></name></person-group> (<year>2010</year>). <article-title>CPHmodels-3.0&#x02014;remote homology modeling using structure-guided sequence profiles</article-title>. <source>Nucleic Acids Res.</source>
<volume>38</volume>, <fpage>W576</fpage>&#x02013;<lpage>W581</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq535</pub-id>, PMID: <?supplied-pmid 20542909?><pub-id pub-id-type="pmid">20542909</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab id="coll1">N. R. Council</collab></person-group> (<year>2010</year>). <source>Acute exposure guideline levels for selected airborne chemicals. Peracetic acid, acute exposure guideline levels</source>. <publisher-loc>Washington</publisher-loc>: <publisher-name>National Academies Press</publisher-name>.</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>T.</given-names></name><name><surname>Shibata</surname><given-names>H.</given-names></name><name><surname>Kawamori</surname><given-names>T.</given-names></name><name><surname>Iimuro</surname><given-names>M.</given-names></name><name><surname>Sugimura</surname><given-names>T.</given-names></name><name><surname>Wakabayashi</surname><given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>Marked reduction of helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>285</volume>, <fpage>728</fpage>&#x02013;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.2001.5229</pub-id>, PMID: <?supplied-pmid 11453654?><pub-id pub-id-type="pmid">11453654</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oono</surname><given-names>H.</given-names></name><name><surname>Hatai</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Antifungal activities of bronopol and 2-methyl-4-isothiazolin-3-one (MT) against <italic>Saprolegnia</italic></article-title>. <source>Biocontrol Sci.</source>
<volume>12</volume>, <fpage>145</fpage>&#x02013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.4265/bio.12.145</pub-id>, PMID: <?supplied-pmid 18198720?><pub-id pub-id-type="pmid">18198720</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otero</surname><given-names>J. M.</given-names></name><name><surname>Noel</surname><given-names>A. J.</given-names></name><name><surname>Guardado-Calvo</surname><given-names>P.</given-names></name><name><surname>Llamas-Saiz</surname><given-names>A. L.</given-names></name><name><surname>Wende</surname><given-names>W.</given-names></name><name><surname>Schierling</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>High-resolution structures of <italic>Thermus thermophilus</italic> enoyl-acyl carrier protein reductase in the apo form, in complex with NAD+ and in complex with NAD+ and triclosan</article-title>. <source>Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun.</source>
<volume>68</volume>, <fpage>1139</fpage>&#x02013;<lpage>1148</lpage>. <pub-id pub-id-type="doi">10.1107/S1744309112033982</pub-id>, PMID: <?supplied-pmid 23027736?><pub-id pub-id-type="pmid">23027736</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otero</surname><given-names>E.</given-names></name><name><surname>Vergara</surname><given-names>S.</given-names></name><name><surname>Robledo</surname><given-names>S. M.</given-names></name><name><surname>Cardona</surname><given-names>W.</given-names></name><name><surname>Carda</surname><given-names>M.</given-names></name><name><surname>Velez</surname><given-names>I. D.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Synthesis, leishmanicidal and cytotoxic activity of triclosan-chalcone, triclosan-chromone and triclosan-coumarin hybrids</article-title>. <source>Molecules</source>
<volume>19</volume>, <fpage>13251</fpage>&#x02013;<lpage>13266</lpage>. <pub-id pub-id-type="doi">10.3390/molecules190913251</pub-id>, PMID: <?supplied-pmid 25170948?><pub-id pub-id-type="pmid">25170948</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;z</surname><given-names>M.</given-names></name><name><surname>Inanan</surname><given-names>B. E.</given-names></name><name><surname>Dikel</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Effect of boric acid in rainbow trout (<italic>Oncorhynchus mykiss</italic>) growth performance</article-title>. <source>J. Appl. Anim. Res.</source>
<volume>46</volume>, <fpage>990</fpage>&#x02013;<lpage>993</lpage>. <pub-id pub-id-type="doi">10.1080/09712119.2018.1450258</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panek</surname><given-names>M.</given-names></name><name><surname>Tomsovsky</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>In vitro growth response of <italic>Phytophthora cactorum</italic>, P. nicotianae and P. x pelgrandis to antibiotics and fungicides</article-title>. <source>Folia Microbiol.</source>
<volume>62</volume>, <fpage>269</fpage>&#x02013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1007/s12223-017-0493-z</pub-id>, PMID: <?supplied-pmid 28127667?><pub-id pub-id-type="pmid">28127667</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perfect</surname><given-names>J. R.</given-names></name></person-group> (<year>2017</year>). <article-title>The antifungal pipeline: a reality check</article-title>. <source>Nat. Rev. Drug Discov.</source>
<volume>16</volume>, <fpage>603</fpage>&#x02013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1038/nrd.2017.46</pub-id>, PMID: <?supplied-pmid 28496146?><pub-id pub-id-type="pmid">28496146</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plumb</surname><given-names>J. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Overview of warmwater fish diseases</article-title>. <source>J. Appl. Aquac.</source>
<volume>9</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1300/j028v09n02_01</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plumed-Ferrer</surname><given-names>C.</given-names></name><name><surname>von Wright</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Antimicrobial activity of weak acids in liquid feed fermentations, and its effects on yeasts and lactic acid bacteria</article-title>. <source>J. Sci. Food Agric.</source>
<volume>91</volume>, <fpage>1032</fpage>&#x02013;<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1002/jsfa.4278</pub-id>, PMID: <?supplied-pmid 21328352?><pub-id pub-id-type="pmid">21328352</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pottinger</surname><given-names>T. G.</given-names></name><name><surname>Day</surname><given-names>J. G.</given-names></name></person-group> (<year>1999</year>). <article-title>A <italic>Saprolegnia parasitica</italic> challenge system for rainbow trout: assessment of Pyceze as an anti-fungal agent for both fish and ova</article-title>. <source>Dis. Aquat. Org.</source>
<volume>36</volume>, <fpage>129</fpage>&#x02013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.3354/dao036129</pub-id>, PMID: <?supplied-pmid 10399041?><pub-id pub-id-type="pmid">10399041</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>D. A.</given-names></name><name><surname>Nahata</surname><given-names>M. C.</given-names></name></person-group> (<year>1982</year>). <article-title>Chloramphenicol: new perspectives on an old drug</article-title>. <source>Drug Intell. Clin. Pharm.</source>
<volume>16</volume>, <fpage>295</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1177/106002808201600404</pub-id>, PMID: <?supplied-pmid 7040026?><pub-id pub-id-type="pmid">7040026</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pull</surname><given-names>L.</given-names></name><name><surname>Lupoglazoff</surname><given-names>J. M.</given-names></name><name><surname>Beardmore</surname><given-names>M.</given-names></name><name><surname>Michel</surname><given-names>J. F.</given-names></name><name><surname>Buffet</surname><given-names>P.</given-names></name><name><surname>Bouchaud</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Artenimol-piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort</article-title>. <source>Malar. J.</source>
<volume>18</volume>:<fpage>419</fpage>. <pub-id pub-id-type="doi">10.1186/s12936-019-3047-9</pub-id>, PMID: <?supplied-pmid 31843017?><pub-id pub-id-type="pmid">31843017</pub-id></mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezinciuc</surname><given-names>S.</given-names></name><name><surname>Sandoval-Sierra</surname><given-names>J. V.</given-names></name><name><surname>Dieguez-Uribeondo</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular identification of a bronopol tolerant strain of <italic>Saprolegnia</italic> australis causing egg and fry mortality in farmed brown trout, <italic>Salmo trutta</italic></article-title>. <source>Fungal Biol.</source>
<volume>118</volume>, <fpage>591</fpage>&#x02013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/j.funbio.2013.11.011</pub-id>, PMID: <?supplied-pmid 25088073?><pub-id pub-id-type="pmid">25088073</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooke</surname><given-names>D. M.</given-names></name><name><surname>Shattock</surname><given-names>R.</given-names></name></person-group> (<year>1983</year>). <article-title>Effect of chloramphenicol and streptomycin on developmental stages of Phytophthom infestans</article-title>. <source>Microbiology</source>
<volume>129</volume>, <fpage>3401</fpage>&#x02013;<lpage>3410</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-129-11-3401</pub-id></mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saegeman</surname><given-names>V. S.</given-names></name><name><surname>Ectors</surname><given-names>N. L.</given-names></name><name><surname>Lismont</surname><given-names>D.</given-names></name><name><surname>Verduyckt</surname><given-names>B.</given-names></name><name><surname>Verhaegen</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Short&#x02010; and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts</article-title>. <source>Burns</source>
<volume>34</volume>, <fpage>205</fpage>&#x02013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2007.02.009</pub-id>, PMID: <?supplied-pmid 18037568?><pub-id pub-id-type="pmid">18037568</pub-id></mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweizer</surname><given-names>H. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Triclosan: a widely used biocide and its link to antibiotics</article-title>. <source>FEMS Microbiol. Lett.</source>
<volume>202</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2001.tb10772.x</pub-id>, PMID: <?supplied-pmid 11506900?><pub-id pub-id-type="pmid">11506900</pub-id></mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeliger</surname><given-names>D.</given-names></name><name><surname>de Groot</surname><given-names>B. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Ligand docking and binding site analysis with PyMOL and Autodock/Vina</article-title>. <source>J. Comput. Aided Mol. Des.</source>
<volume>24</volume>, <fpage>417</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-010-9352-6</pub-id>, PMID: <?supplied-pmid 20401516?><pub-id pub-id-type="pmid">20401516</pub-id></mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Characterization of the putative tryptophan synthase beta-subunit from <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Acta Biochim. Biophys. Sin.</source>
<volume>41</volume>, <fpage>379</fpage>&#x02013;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmp017</pub-id>, PMID: <?supplied-pmid 19430702?><pub-id pub-id-type="pmid">19430702</pub-id></mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>K.</given-names></name><name><surname>Kasuga</surname><given-names>O.</given-names></name><name><surname>Yasoshima</surname><given-names>A.</given-names></name><name><surname>Matsushita</surname><given-names>T.</given-names></name><name><surname>Kawakami</surname><given-names>Y.</given-names></name></person-group> (<year>1997</year>). <article-title>Bactericidal effect of ecabet sodium on clarithromycin&#x02010; and metronidazole-resistant clinical isolates of Helicobacter pylori</article-title>. <source>Jpn. J. Antibiot.</source>
<volume>50</volume>, <fpage>525</fpage>&#x02013;<lpage>531</lpage>. PMID: <?supplied-pmid 9258741?><pub-id pub-id-type="pmid">9258741</pub-id></mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solanki</surname><given-names>V.</given-names></name><name><surname>Tiwari</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>). <article-title>Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against <italic>Acinetobacter baumannii</italic></article-title>. <source>Sci. Rep.</source>
<volume>8</volume>:<fpage>9044</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-26689-7</pub-id>, PMID: <?supplied-pmid 29899345?><pub-id pub-id-type="pmid">29899345</pub-id></mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>V.</given-names></name><name><surname>Rezinciuc</surname><given-names>S.</given-names></name><name><surname>Bulone</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>). <article-title>Quantitative proteomic analysis of four developmental stages of <italic>Saprolegnia parasitica</italic></article-title>. <source>Front. Microbiol.</source>
<volume>8</volume>:<fpage>2658</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.02658</pub-id>, PMID: <?supplied-pmid 29375523?><pub-id pub-id-type="pmid">29375523</pub-id></mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Sinha</surname><given-names>R.</given-names></name><name><surname>Roy</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>Toxicological effects of malachite green</article-title>. <source>Aquat. Toxicol.</source>
<volume>66</volume>, <fpage>319</fpage>&#x02013;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1016/j.aquatox.2003.09.008</pub-id>, PMID: <?supplied-pmid 15129773?><pub-id pub-id-type="pmid">15129773</pub-id></mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stueland</surname><given-names>S.</given-names></name><name><surname>Heier</surname><given-names>B. T.</given-names></name><name><surname>Skaar</surname><given-names>I.</given-names></name></person-group> (<year>2005</year>). <article-title>A simple in vitro screening method to determine the effects of drugs against growth of <italic>Saprolegnia parasitica</italic></article-title>. <source>Mycol. Prog.</source>
<volume>4</volume>, <fpage>273</fpage>&#x02013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1007/s11557-006-0131-7</pub-id></mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>X. L.</given-names></name></person-group> (<year>2014</year>). <article-title>The efficacy of copper sulfate in controlling infection of <italic>Saprolegnia parasitica</italic></article-title>. <source>J. World Aquacult. Soc.</source>
<volume>45</volume>, <fpage>220</fpage>&#x02013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1111/jwas.12113</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surolia</surname><given-names>N.</given-names></name><name><surname>Surolia</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of <italic>Plasmodium falciparum</italic></article-title>. <source>Nat. Med.</source>
<volume>7</volume>, <fpage>167</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1038/84612</pub-id>, PMID: <?supplied-pmid 11175846?><pub-id pub-id-type="pmid">11175846</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>K.</given-names></name><name><surname>Kajiwara</surname><given-names>H.</given-names></name><name><surname>Imamura</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Oridamycins A and B, anti-<italic>Saprolegnia parasitica</italic> indolosesquiterpenes isolated from <italic>Streptomyces</italic> sp. KS84</article-title>. <source>J. Nat. Prod.</source>
<volume>73</volume>, <fpage>698</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1021/np1000522</pub-id>, PMID: <?supplied-pmid 20369841?><pub-id pub-id-type="pmid">20369841</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Sakai</surname><given-names>K.</given-names></name><name><surname>Nagano</surname><given-names>Y.</given-names></name><name><surname>Orui Sakaguchi</surname><given-names>S.</given-names></name><name><surname>Lima</surname><given-names>A. O.</given-names></name><name><surname>Pellizari</surname><given-names>V. H.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Cladomarine, a new anti-saprolegniasis compound isolated from the deep-sea fungus, Penicillium coralligerum YK-247</article-title>. <source>J. Antibiot.</source>
<volume>70</volume>, <fpage>911</fpage>&#x02013;<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2017.58</pub-id>, PMID: <?supplied-pmid 28559580?><pub-id pub-id-type="pmid">28559580</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>H. Q.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>R. X.</given-names></name></person-group> (<year>2000</year>). <article-title>Terpenoids and flavonoids from <italic>Artemisia</italic> species</article-title>. <source>Planta Med.</source>
<volume>66</volume>, <fpage>391</fpage>&#x02013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1055/s-2000-8538</pub-id>, PMID: <?supplied-pmid 10865468?><pub-id pub-id-type="pmid">10865468</pub-id></mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tedesco</surname><given-names>P.</given-names></name><name><surname>Fioravanti</surname><given-names>M. L.</given-names></name><name><surname>Galuppi</surname><given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>In vitro activity of chemicals and commercial products against <italic>Saprolegnia parasitica</italic> and <italic>Saprolegnia delica</italic> strains</article-title>. <source>J. Fish Dis.</source>
<volume>42</volume>, <fpage>237</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1111/jfd.12923</pub-id>, PMID: <?supplied-pmid 30536642?><pub-id pub-id-type="pmid">30536642</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>NTP technical report on the toxicity studies of formic acid (CAS no. 64-18-6) administered by inhalation to F344/N rats and B6C3F1 mice</article-title>. <source>Toxic. Rep. Ser.</source>
<volume>19</volume>, <fpage>D1</fpage>&#x02013;<lpage>D3</lpage>. PMID: <?supplied-pmid 12209187?><pub-id pub-id-type="pmid">12209187</pub-id></mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tidy</surname><given-names>H.</given-names></name></person-group> (<year>1915</year>). <article-title>The strength of picric acid as an antiseptic</article-title>. <source>Lancet</source>
<volume>186</volume>, <fpage>604</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(00)54228-7</pub-id></mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trott</surname><given-names>O.</given-names></name><name><surname>Olson</surname><given-names>A. J.</given-names></name></person-group> (<year>2010</year>). <article-title>AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title>. <source>J. Comput. Chem.</source>
<volume>31</volume>, <fpage>455</fpage>&#x02013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id>, PMID: <?supplied-pmid 19499576?><pub-id pub-id-type="pmid">19499576</pub-id></mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Slooten</surname><given-names>C.</given-names></name><name><surname>Peperzak</surname><given-names>L.</given-names></name><name><surname>Buma</surname><given-names>A. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Assessment of didecyldimethylammonium chloride as a ballast water treatment method</article-title>. <source>Environ. Technol.</source>
<volume>36</volume>, <fpage>435</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1080/09593330.2014.951401</pub-id>, PMID: <?supplied-pmid 25182049?><pub-id pub-id-type="pmid">25182049</pub-id></mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van West</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title><italic>Saprolegnia parasitica</italic>, an oomycete pathogen with a fishy appetite: new challenges for an old problem</article-title>. <source>Mycologist</source>
<volume>20</volume>, <fpage>99</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.mycol.2006.06.004</pub-id></mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrilow</surname><given-names>A. G.</given-names></name><name><surname>Hull</surname><given-names>C. M.</given-names></name><name><surname>Rolley</surname><given-names>N. J.</given-names></name><name><surname>Parker</surname><given-names>J. E.</given-names></name><name><surname>Nes</surname><given-names>W. D.</given-names></name><name><surname>Smith</surname><given-names>S. N.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Clotrimazole as a potent agent for treating the oomycete fish pathogen <italic>Saprolegnia parasitica</italic> through inhibition of sterol 14alpha-demethylase (CYP51)</article-title>. <source>Appl. Environ. Microbiol.</source>
<volume>80</volume>, <fpage>6154</fpage>&#x02013;<lpage>6166</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01195-14</pub-id>, PMID: <?supplied-pmid 25085484?><pub-id pub-id-type="pmid">25085484</pub-id></mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>J. J.</given-names></name><name><surname>Rodman</surname><given-names>J. S.</given-names></name><name><surname>Peterson</surname><given-names>C. M.</given-names></name></person-group> (<year>1984</year>). <article-title>A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis</article-title>. <source>N. Engl. J. Med.</source>
<volume>311</volume>, <fpage>760</fpage>&#x02013;<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198409203111203</pub-id>, PMID: <?supplied-pmid 6472365?><pub-id pub-id-type="pmid">6472365</pub-id></mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willoughby</surname><given-names>L.</given-names></name><name><surname>Roberts</surname><given-names>R.</given-names></name></person-group> (<year>1992</year>). <article-title>Towards strategic use of fungicides against <italic>Saprolegnia parasitica</italic> in salmonid fish hatcheries</article-title>. <source>J. Fish Dis.</source>
<volume>15</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2761.1992.tb00631.x</pub-id></mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>D. S.</given-names></name><name><surname>Feunang</surname><given-names>Y. D.</given-names></name><name><surname>Guo</surname><given-names>A. C.</given-names></name><name><surname>Lo</surname><given-names>E. J.</given-names></name><name><surname>Marcu</surname><given-names>A.</given-names></name><name><surname>Grant</surname><given-names>J. R.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>. <source>Nucleic Acids Res.</source>
<volume>46</volume>, <fpage>D1074</fpage>&#x02013;<lpage>D1082</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>, PMID: <?supplied-pmid 29126136?><pub-id pub-id-type="pmid">29126136</pub-id></mixed-citation></ref><ref id="ref100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xaplanteri</surname><given-names>M. A.</given-names></name><name><surname>Andreou</surname><given-names>A.</given-names></name><name><surname>Dinos</surname><given-names>G. P.</given-names></name><name><surname>Kalpaxis</surname><given-names>D. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Effect of polyamines on the inhibition of peptidyltransferase by antibiotics: revisiting the mechanism of chloramphenicol action</article-title>. <source>Nucleic Acids Res.</source>
<volume>31</volume>, <fpage>5074</fpage>&#x02013;<lpage>5083</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg686</pub-id>, PMID: <?supplied-pmid 12930958?><pub-id pub-id-type="pmid">12930958</pub-id></mixed-citation></ref><ref id="ref101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue-Gang</surname><given-names>H.</given-names></name><name><surname>Lei</surname><given-names>L.</given-names></name><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Kun</surname><given-names>H.</given-names></name><name><surname>Xian-Le</surname><given-names>Y.</given-names></name><name><surname>Gao-Xue</surname><given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>In vitro screening of Chinese medicinal plants for antifungal activity against <italic>Saprolegnia</italic> sp. and <italic>Achlya klebsiana</italic></article-title>. <source>N. Am. J. Aquac.</source>
<volume>75</volume>, <fpage>468</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1080/15222055.2013.808298</pub-id></mixed-citation></ref><ref id="ref102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimatsu</surname><given-names>T.</given-names></name><name><surname>Hiyama</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Mechanism of the action of didecyldimethylammonium chloride (DDAC) against <italic>Escherichia coli</italic> and morphological changes of the cells</article-title>. <source>Biocontrol Sci.</source>
<volume>12</volume>, <fpage>93</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.4265/bio.12.93</pub-id>, PMID: <?supplied-pmid 17927049?><pub-id pub-id-type="pmid">17927049</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>CDD</term><def><p>Conserved domain database</p></def></def-item><def-item><term>DDAC</term><def><p>Didecyldimethylammonium chloride</p></def></def-item><def-item><term>DEG</term><def><p>Database of essential genes</p></def></def-item><def-item><term>DHFR</term><def><p>Dihydrofolate reductase</p></def></def-item><def-item><term>DHPS</term><def><p>Dihydropteroate synthase</p></def></def-item><def-item><term>DMSO</term><def><p>Dimethyl sulfoxide</p></def></def-item><def-item><term>FDA</term><def><p>Food and drug administration</p></def></def-item><def-item><term>PDA</term><def><p>Potato dextrose agar</p></def></def-item><def-item><term>SDR</term><def><p>Short-chain dehydrogenases/reductases</p></def></def-item></def-list></glossary></back></article>